1.Sherry Culhane — Cross/Redirect (Part 2)
2,014 linesTHE COURT: At this time the Court calls the State of Wisconsin vs. Steven Avery, Case No. 05 CF 381. We're here this morning for a continuation of the trial in this matter. Will the parties state their appearances for the record, please.
MR. KRATZ: Good morning, Judge. The State appears by Special Prosecutors Ken Kratz, Norm Gahn and Tom Fallon.
MR. STRANG: Good morning. As well, Steven Avery is in person and Dean Strang and Jerome Buting representing.
THE COURT: All right. Before we begin, I would like to commend the jurors for all getting here on time this morning. When I called the Clerk to notify you last night that we would be having court today, I didn't expect as much snow as I found when I got up this morning. I appreciate the fact, I'm sure you made an effort to get to the bus stop on time.
When we left off on Friday, I believe the defense was about to begin its cross-examination of Ms Culhane; is that correct?
MR. BUTING: That is correct, your Honor.
THE COURT: All right. You can have the witness brought in and begin.
SHERRY CULHANE, called as a witness herein, having been first duly sworn, was examined and testified as follows:
COURT CLERK: Please be seated. Please state your name and spell your last name for the record.
SHERRY CULHANE: Sherry Culhane, C-u-l-h-a-n-e.
THE COURT: All right. Mr. Buting, you may begin.
MR. BUTING: Thank you, Judge.
CROSS-EXAMINATION BY ATTORNEY BUTING:
MR. BUTING: Good morning, ma'am.
SHERRY CULHANE: Good morning.
MR. BUTING: I want to pick up on where you left off on Friday, and that is your opinions, series of opinions about the stains that you found in the RAV4. Okay, are you with me?
SHERRY CULHANE: Mm-hmm.
MR. BUTING: Your opinion, over and over to Mr. Gahn was, do you have an opinion to a reasonable degree of scientific certainty as to whether Mr. Avery is the source of the DNA found in stains one, two, three, whatever it was, right?
SHERRY CULHANE: Right.
MR. BUTING: And what you are really saying is, that as far as you can tell, Mr. Avery is the original source of the DNA that you find in those stains, correct?
SHERRY CULHANE: I'm saying that his profile was consistent with what I found in the stains.
MR. BUTING: Right. But what you are not saying is anything about how his DNA found its way inside the RAV4, are you?
MR. BUTING: Your tests aren't designed to tell us how his DNA found it's way into the location where you ultimately swabbed, are they?
MR. BUTING: What you are looking for is a DNA profile, and if you find it, then you compare it to a known reference sample, in this case, Mr. Avery, right?
SHERRY CULHANE: Right.
MR. BUTING: But if someone else planted Mr. Avery's DNA, or blood, or both, inside that vehicle, you wouldn't know that from these tests, would you?
MR. BUTING: So you cannot tell this jury, with any degree of certainty, scientific or otherwise, that Steven Avery was, himself, ever inside that vehicle, can you?
MR. BUTING: No meaning correct?
SHERRY CULHANE: That's correct.
MR. BUTING: All right. You also talked about contamination, and I think you used the word unintentional contamination; do you recall a discussion about that?
SHERRY CULHANE: Yes, I do.
MR. BUTING: All of the quality controls that you set up inside the Wisconsin Crime Lab are designed to deal with evidence after it arrives at your lab, correct?
SHERRY CULHANE: That's correct.
MR. BUTING: You can't do anything about contamination that might occur to evidence before it gets to your lab, right?
SHERRY CULHANE: That's correct.
MR. BUTING: And that would be true for unintentional contamination such as an officer who's sloppy at the scene when he's picking up whatever evidence it may be?
SHERRY CULHANE: That's correct.
MR. BUTING: Your tests and your quality control doesn't -- can't account for that, right?
SHERRY CULHANE: Right.
MR. BUTING: And that also would be true as to intentional contamination that occurred before it gets to your lab as well, right?
SHERRY CULHANE: Correct.
MR. BUTING: Once again, so you have no way, through your quality control tests, controlling whether or not there's some intentional, deliberate tampering with the evidence that goes -- that takes place before it gets to your lab?
SHERRY CULHANE: That's correct.
MR. BUTING: So if the evidence had been intentionally contaminated or tampered with, before it got to your lab, your tests will not show that; isn't that right?
SHERRY CULHANE: That's correct.
MR. BUTING: Now, I'm assuming that you would agree with me on this, that normally evidence that you receive from a -- an agency that is police is -- you are assuming that when you get it that the -- that there's good integrity with that evidence, right?
SHERRY CULHANE: Correct.
MR. BUTING: That is, you trust the police to be honest and fair in an investigation, generally, right?
SHERRY CULHANE: Correct.
MR. BUTING: Just as we and the jury would trust you and other members of the Wisconsin Crime Lab to be honest and fair in your investigation?
SHERRY CULHANE: That's correct.
MR. BUTING: And the reason that we can normally be comfortable with that assumption, with regard to your Crime Lab, is that you would never knowingly assign an analyst to examine case evidence who had some connection to a suspect, would you?
MR. BUTING: And I'm sure, for instance, you, yourself, if you had been deposed as a witness in a lawsuit brought by a suspect, you would not volunteer to be the person who runs the tests in that case, would you?
MR. BUTING: And you would -- If you knew that one of your other analysts was also similarly situated with regard to a suspect, you would not assign that analyst to be handling the evidence and making the tests that are done in the case, would you?
SHERRY CULHANE: Not if they had a personal attachment to anyone in the case, no.
MR. BUTING: Sure. Because it's important for you that your lab be objective in its results, correct?
SHERRY CULHANE: Correct.
MR. BUTING: And you are aware -- you said that you go to meetings, forensic scientists test meetings and that sort of thing, right?
SHERRY CULHANE: Correct.
MR. BUTING: You are aware that some labs in other parts of the country have had trouble with that, right, where analysts have been actually accused of falsifying results?
MR. BUTING: Well, I think it goes to her procedures here.
THE COURT: I'm going to sustain the objection. I think the point has been made.
MR. BUTING: (By Attorney Buting)~ Well, would you agree with me that if somebody in your lab was so predisposed, it would be very easily -- very easy for that person to frame a suspect?
THE COURT: I'm going to sustain the objection. I will allow this line of questioning, but the hypothetical fact scenario will have to be a little bit more specific.
MR. BUTING: (By Attorney Buting)~ If somebody in your lab wanted to monkey with the evidence and plant it in a way that deliberately framed a suspect, that could be done, couldn't it?
THE COURT: It's sustained.
MR. BUTING: (By Attorney Buting)~ If somebody wanted to take and deliberately contaminate evidence, once it got to your lab, deliberately contaminate evidence, and let's say, put or mix a reference sample from the suspect, with actual evidence in the case, that could be done, couldn't it?
SHERRY CULHANE: It's possible that that could be done, but --
MR. BUTING: Sure.
SHERRY CULHANE: -- in my opinion that wouldn't happen.
MR. BUTING: Of course not. Because you take steps to be sure that the person assigned to the case would have no such inclination to do so; isn't that right?
SHERRY CULHANE: That's correct.
MR. BUTING: And you take steps to be sure that the person assigned to the case has no stake in the outcome of the testing itself or the case?
MR. BUTING: If she needs clarification she can ask.
THE COURT: Yeah, she can answer that.
SHERRY CULHANE: I'm sorry, could you repeat that.
MR. BUTING: You take steps to be sure that the person assigned to a case has no stake in the outcome of the case or the test?
SHERRY CULHANE: That's correct.
MR. BUTING: All right. And, indeed, it's your assumption that when evidence comes to you from a police agency, it's your assumption that the police have also taken similar stakes -- or similar steps to make sure that nobody connected with the suspect has been involved in the collection of the evidence, isn't it?
MR. BUTING: Asking for her assumption.
THE COURT: She can answer.
SHERRY CULHANE: Okay. Obviously, I don't know any of this for a fact, but I would make the assumption that evidence came in from the police agency was -- maintained integrity.
MR. BUTING: And collected from somebody who had no connection to the case, you would hope?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, in this case, I believe you said that some of your duties involve case flow and case management, right?
SHERRY CULHANE: Correct.
MR. BUTING: Does that also involve assigning particular analysts to a particular case?
SHERRY CULHANE: Yes.
MR. BUTING: But in this case, you assigned yourself?
SHERRY CULHANE: Correct.
MR. BUTING: All right. And that's a decision that you make, and yours alone?
SHERRY CULHANE: Most of the time, sometimes my supervisor makes that decision but, in this case, I made the decision.
MR. BUTING: All right. Mr. Gahn pointed out that you were actually the analyst who did the tests that resulted in exoneration of Mr. Avery in 2003, right?
SHERRY CULHANE: Correct.
MR. BUTING: And you did that because -- in part, because newer, more accurate DNA results -- or tests had been developed that actually excluded Mr. Avery as the source of a pubic hair?
SHERRY CULHANE: Correct, at the time the original case was worked, DNA was not available.
MR. BUTING: Okay. But I want to get into just a little bit about what that involved. What you tested were pubic hairs that were found, essentially, on -- in the area of the victim's privates, right?
SHERRY CULHANE: From her pubic area, yes.
MR. BUTING: These are combings that are done to find any possible pubic hairs from the assailant?
SHERRY CULHANE: Correct.
MR. BUTING: And your test in 2003 absolutely, positively, excluded Mr. Avery as the source of one of those hairs, right?
SHERRY CULHANE: Correct.
MR. BUTING: There was no question about that, right?
SHERRY CULHANE: Correct.
MR. BUTING: And it included -- or matched, a fellow by the name of Gregory Allen, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you knew that Allen was no friend of the victim, so that his pubic hair shouldn't be found where they were, right?
SHERRY CULHANE: I really didn't have any knowledge of whether she knew him or not, no.
MR. BUTING: Okay. But you knew that his hairs -- or that his DNA profile was registered in CODIS.
SHERRY CULHANE: That's correct.
MR. BUTING: And that, in fact, he was already in prison at the time of 2003 when you did this test?
SHERRY CULHANE: That's correct.
MR. BUTING: In prison for a rape that he committed after, or while Mr. Avery sat in prison for Mr. Allen's crime.
SHERRY CULHANE: That's correct.
MR. BUTING: Now, what Mr. Gahn didn't have you point out, though, let's get into a few other things; although you were the one who exonerated -- or whose test exonerated Mr. Avery, the evidence sat at your lab for more than a year before you got around to doing the test that did exonerate him, right?
SHERRY CULHANE: That's correct.
MR. BUTING: And one of the things that you in fact said you do is control priorities and case flow of what gets tested when, right?
SHERRY CULHANE: Correct.
MR. BUTING: So, had you done that test as soon as it came in, the evidence being in September of 2002, I believe, Mr. Avery would have been exonerated then, wouldn't he?
SHERRY CULHANE: Correct.
MR. BUTING: So Mr. Avery sat for another year, in prison, because of the delays that resulted in your Crime Lab; isn't that right?
SHERRY CULHANE: Correct.
MR. BUTING: Another thing Mr. Gahn didn't point out is another irony in this case. Not only were you involved in the 2003 exoneration of Mr. Avery, but you were also involved in the 1985 conviction of Mr. Avery, weren't you?
SHERRY CULHANE: I worked evidence on that case, yes.
MR. BUTING: And you testified as a witness for the prosecution at trial in that case, didn't you?
SHERRY CULHANE: Yes, I testified.
MR. BUTING: In fact, the trial where he had 16 alibi witnesses and was convicted included your expert opinion regarding some hairs that had been found and were offered by the prosecution to somehow link Mr. Avery to that crime; isn't that right?
SHERRY CULHANE: To be perfectly honest, I do not remember my entire testimony from 1985.
MR. BUTING: Well, I have it here, if you need to refer to it. But I don't know that we'll get into that much detail.
SHERRY CULHANE: Okay.
MR. BUTING: I just want the jury to understand a little background, okay?
SHERRY CULHANE: Sure.
MR. BUTING: You do recall that you testified, generally, in those terms, right?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. And just so we understand, there were no DNA tests back in 1985?
SHERRY CULHANE: Correct.
MR. BUTING: You were testifying about a type of so-called science known as microscopic hair comparison analysis, right?
SHERRY CULHANE: Correct.
MR. BUTING: And the theory behind that science, in 1985, was that you could take a microscope with two fields and that you could put one hair underneath one microscope field and another hair under the other, and you could examine the two of them together, correct?
SHERRY CULHANE: Correct.
MR. BUTING: And the theory being that you could -- you present this to the jury anyway, that you could make some conclusions about how similar, dissimilar, or consistent one hair was to the other?
SHERRY CULHANE: Correct.
MR. BUTING: And I don't mean to be jumping all over you, you were not the only person in the country doing this kind of testimony in 1985, right?
SHERRY CULHANE: That's correct.
MR. BUTING: Forensic labs all over the country were bringing in experts to testify to juries about this kind of science, right?
SHERRY CULHANE: Correct.
MR. BUTING: Including the FBI, right?
SHERRY CULHANE: Yes.
MR. BUTING: Now, with the advent of DNA, the forensic community discovered something about those tests, right?
SHERRY CULHANE: Correct.
MR. BUTING: They discovered that those conclusions or opinions that were being drawn by the experts, such as yourself, were really not all that reliable, didn't they?
SHERRY CULHANE: Correct. They have been proven to be much less specific than DNA analysis.
MR. BUTING: All right. And even wrong on occasions, right?
SHERRY CULHANE: Correct.
MR. BUTING: So, for instance, in the 1985 trial of Mr. Avery, there were some hairs found, head hairs I think, found on a T-shirt that he was wearing on the day of this poor woman's rape, right?
SHERRY CULHANE: I don't recall exactly.
MR. BUTING: Well, okay. Do you recall giving an opinion that one hair found on Mr. Avery's T-shirt appeared to be similar to or consistent with a head hair standard of the victim in that case?
SHERRY CULHANE: No, I don't recall exactly. I'm assuming it's in my report, but I don't have independent recollection of that.
MR. BUTING: Would you like to take a moment to review --
SHERRY CULHANE: Yes, sir.
MR. BUTING: -- a portion of your transcript?
SHERRY CULHANE: Yes, sir, I can.
MR. GAHN: Your Honor, at this time I just question the relevancy of this to the testimony that Ms Culhane gave in this case, the relevancy in this 1985 case.
THE COURT: Mr. Buting.
MR. BUTING: Mr. Gahn tried to present her as a totally unbiased witness for them, in the event that because she -- her test in 2003 resulted in the exoneration, I think the jury needs to hear that she's also testified the other way for the prosecution at the beginning of the trial.
THE COURT: As I understand your line of questioning, it's an attack on the methodology that was used at the time, not on her credibility.
MR. BUTING: Also a question on her opinion and the validity of her opinions.
THE COURT: No, I'm going to sustain the objection.
MR. BUTING: All right.
MR. BUTING: (By Attorney Buting)~ Let's do it this way. Would you agree with me that at least -- that hair comparison, microscopic hair comparison, so-called forensic science, is one example of how science is not necessarily or -- or our understanding of science is not necessarily infallible, is it?
SHERRY CULHANE: No. With respect to hair analysis, that was a much less objective criteria than what we use today. That was more subjective and open to interpretation -- personal interpretation. The science that we use now, today, with DNA, is much more objective and much more reliable.
MR. BUTING: Okay. But at the time you were presenting testimony you expressed it in terms of a reasonable degree of scientific certainty, didn't you?
SHERRY CULHANE: In 1985, I do not remember how I stated that.
MR. BUTING: Well, in general, whether in Mr. Avery's case or any of the other cases where you presented this kind of hair comparison testimony, you presented opinions to juries or to Courts, to a reasonable degree of scientific certainty, didn't you?
THE COURT: Sustained.
MR. BUTING: As to which, asked and answered or relevance?
THE COURT: To relevancy.
MR. BUTING: All right.
MR. BUTING: (By Attorney Buting)~ When you talked about DNA and what it is and how it's examined, you mentioned -- Oh, by the way, before I leave that, to your knowledge, your lab isn't going around doing those kind of -- providing that kind of testimony anymore, hair comparison testimony anymore, are you?
MR. BUTING: And neither is the FBI, right?
SHERRY CULHANE: I'm not sure about that.
MR. BUTING: Okay. But going back to DNA, you said that -- and I don't have your -- the power point slides, but I think the jury can probably recall them -- you showed this double helix kind of spiral thing being unwound and bracketing off certain areas of it, right?
SHERRY CULHANE: Correct.
MR. BUTING: And you talked about a part that was considered a gene and a part that is not a gene, or something like that?
SHERRY CULHANE: I referred to the parts that do not function as genes, and they are referred to as genetic markers.
MR. BUTING: Okay. And -- Well, I don't know if you got into this or not, but let's just briefly touch on this. When we're talking about genetics, you recognize that certain genes are inherited by everybody, right? The genes, for instance, that make humans have two eyes instead of one, right?
SHERRY CULHANE: Correct.
MR. BUTING: Two arms instead of one?
SHERRY CULHANE: Correct.
MR. BUTING: Or two legs, right?
SHERRY CULHANE: Yes.
MR. BUTING: There were certain genes that are common to everybody, unless there is some sort of birth defect or genetic mutation, right?
SHERRY CULHANE: Correct.
MR. BUTING: And so, if you find a gene that says -- that determines that this individual should have two eyes, or two legs, or two arms, that's kind of meaningless in terms of identifying a suspect, isn't it?
SHERRY CULHANE: Well, first of all, we don't even look at those portions at all.
MR. BUTING: I understand.
SHERRY CULHANE: So it's irrelevant.
MR. BUTING: But if you were to look at genes that everybody has and find them in a profile, that would be meaningless?
SHERRY CULHANE: Correct.
MR. BUTING: For your purposes?
SHERRY CULHANE: Yes.
MR. BUTING: As you would say, that would have zero discriminating power?
SHERRY CULHANE: Correct.
MR. BUTING: Okay. And other more common types of genes, however, are sort of individually inherited. Like the gene that would say what color your hair should be, may be different from what someone else has, right?
SHERRY CULHANE: Yes.
MR. BUTING: Or what your eye color may be, right?
SHERRY CULHANE: Correct.
MR. BUTING: Or how tall or how short you are, ultimately, going to be when you grow up?
SHERRY CULHANE: Correct.
MR. BUTING: Those are sort of more individual genetic characteristics that are inherited at different rates in the population?
SHERRY CULHANE: Correct.
MR. BUTING: Same thing with whether you are Type A, or Type B blood, or Type O positive, or whatever?
SHERRY CULHANE: Correct.
MR. BUTING: And there are data banks, then, statistics that can say, you know, what are the odds, or what are the chances of finding, you know, a random man population, somebody with blue eyes?
SHERRY CULHANE: I don't know about that. I don't know if there's a --
MR. BUTING: You are a serologist, so let me focus on that. There are statistics that talk about -- that tell you what percentage of the population is Type A blood?
SHERRY CULHANE: Correct.
MR. BUTING: And type B and so forth, right?
SHERRY CULHANE: Yes.
MR. BUTING: And those are well-known statistics that have been developed over years of study?
SHERRY CULHANE: Yes.
MR. BUTING: Now, in fact, we know, or we're learning, what genes actually determine someone to be -- to have certain characteristics, physical or biological characteristics, right?
SHERRY CULHANE: Yes.
MR. BUTING: Some diseases we're finding are based on a particular gene someone may have, for instance?
SHERRY CULHANE: Yes.
MR. BUTING: Now, with DNA tests, you talked about this area that's not really what you call a gene, but you called it a genetic marker, right?
SHERRY CULHANE: Correct.
MR. BUTING: And it's an area of the DNA that's -- appears to be, I think you used the term hyper variable; do you recall that?
SHERRY CULHANE: I don't recall using that term, but it is -- it's extremely variable in those regions, that's correct.
MR. BUTING: Okay. But you also said that we don't know what those -- what that portion of the DNA is even about, why it's there, do we?
MR. BUTING: We don't know what it does, why we would have a marker that would be the D21, blah, blah, blah, number that you come up with in these tests?
SHERRY CULHANE: That's correct.
MR. BUTING: These are just things that we think, at our current level of scientific knowledge, are rather unique from one person to the next, when you put them altogether?
SHERRY CULHANE: Well, they are variable and that's the important part of them, they vary from individual to individual. Scientists don't know what their function is, but for forensics, the important part is that they are different from person to person.
MR. BUTING: Okay. But if science later determines that they are not completely, independently inherited, that they are linked together, that would really make a difference for you, wouldn't it?
SHERRY CULHANE: Yes.
MR. BUTING: Because all of these 1 in a quintillion, or 1 in a billion numbers you come up with are based on the assumption that each one of those 16 numbers on your power point slides are inherited completely independent of each other?
SHERRY CULHANE: That's correct.
MR. BUTING: That is, if someone has a D21 16, they are not necessarily going to be -- also have a VWA 12?
SHERRY CULHANE: That's correct.
MR. BUTING: All right. Let's talk about the testing process just a little bit first, then we'll get into it in more detail. The jury, I think, needs to understand that the tests that you do in your lab, or anyone does in your lab, are not what we would call double blind tests?
SHERRY CULHANE: Could you define what you mean by that.
MR. BUTING: Or even blind tests, you never heard that term?
SHERRY CULHANE: I have heard the term before, I'm not exactly sure how you are using the term. If you could define that for me.
MR. BUTING: Well, okay. Let's say, on a proficiency test that you get, that's sent to you from some lab, outside lab, you have no idea what you are testing, right?
SHERRY CULHANE: Correct.
MR. BUTING: You have no idea what's the suspect sample, what's the elimination sample. You don't know any of that when you do the tests, right?
SHERRY CULHANE: Well, on a proficiency test, we know what the suspect and we know what the victim are.
MR. BUTING: Okay. So, those aren't completely blind either. Let me give you an example what I mean by blind. Someone gives you a sample, two reference standards. And you have no idea who the suspect is and who the extremely unlikely elimination sample is?
SHERRY CULHANE: Okay.
MR. BUTING: All right. And then you get an evidence sample, that's also unknown at that time?
SHERRY CULHANE: Correct.
MR. BUTING: If you just got those three samples and you are just testing them, you have no idea which is which, that's what I mean by blind testing?
SHERRY CULHANE: Okay.
MR. BUTING: All right. That's not what you do in your lab?
MR. BUTING: In your lab, when you get a reference sample, you know -- in fact, you usually know the name of the person whose reference sample you are dealing with?
SHERRY CULHANE: Yes.
MR. BUTING: So when you test Mr. Avery's DNA sample, you knew it was Mr. Avery who you were testing?
SHERRY CULHANE: Yes.
MR. BUTING: Or Delores Avery in her case?
SHERRY CULHANE: Yes.
MR. BUTING: Or Allen Avery in his case, right?
SHERRY CULHANE: Correct.
MR. BUTING: And you know that, and not only do you know who it is you are testing, but you have some idea whether they are considered a suspect in the case or not?
SHERRY CULHANE: That's correct.
MR. BUTING: You know that because you talk with police and prosecutors?
SHERRY CULHANE: That in part and it comes into the laboratory with a suspect and a victim's name.
MR. BUTING: Oh, okay. So when you get it, you already know who the suspect is?
SHERRY CULHANE: If there is a suspect, yes.
MR. BUTING: And in this case, there was a suspect and the name given to that person was Steven Avery, when it came to your lab; isn't that right?
SHERRY CULHANE: Yes.
MR. BUTING: Not only that, you get messages, phone messages and phone conversations, in this case with Mr. Fassbender, right?
SHERRY CULHANE: Yes.
MR. BUTING: And he kind of gives you a heads up on what to look for and, you know, what happened, what they think happened in the case, or at the scene?
SHERRY CULHANE: Correct.
MR. BUTING: And in this case, you got a number of phone calls and messages from Mr. Fassbender, kind of early on in the testing, right?
SHERRY CULHANE: Yes.
(Exhibit No. 341 marked for identification.)
MR. BUTING: I'm showing you Exhibit 341, does that look -- does that form look familiar to you?
SHERRY CULHANE: Yes.
MR. BUTING: This is something that's called a case communication record?
SHERRY CULHANE: Yes.
MR. BUTING: Something that you use in your lab?
SHERRY CULHANE: Correct.
MR. BUTING: And what you do is, when you get a phone call from somebody, you will keep jotting notes as to the gist of the conversation?
SHERRY CULHANE: That's correct.
MR. BUTING: And did you do that in this case?
SHERRY CULHANE: Yes.
MR. BUTING: Is that your initials at the top?
SHERRY CULHANE: Yes.
MR. BUTING: Let me put this up on the ELMO. There we go. All right. I apologize for the delay. Up on the screen, now, is Exhibit 341. And this is one of those phone messages that you got from, in this case, Mr. Fassbender, correct?
SHERRY CULHANE: Yes.
MR. BUTING: You've got a place to indicate that, where it says you check incoming, Fassbender's name, and the date of this is November 11th of 2005, correct?
SHERRY CULHANE: Yes.
MR. BUTING: And the very first thing that is indicated on here is, he is telling you that there's some evidence that is going to be coming or is already here, right?
SHERRY CULHANE: Yes.
MR. BUTING: Here meaning at your lab?
SHERRY CULHANE: Correct.
MR. BUTING: And he says there's going to be a couple of items from the house and the garage, right?
SHERRY CULHANE: Right.
MR. BUTING: And then he says -- or you wrote down, I assume that's him telling you -- try to put her in his house or garage, correct?
SHERRY CULHANE: Correct.
MR. BUTING: So you are being told, before you do any of these tests, that Mr. Fassbender wants you to come up with results that put Teresa Halbach in Mr. Avery's house or garage; isn't that right?
SHERRY CULHANE: I had that information, but that had no bearing on my analysis at all.
MR. BUTING: Of course not, but that's what you are being told to do?
SHERRY CULHANE: That was information in the investigation.
MR. BUTING: That's what Mr. Fassbender told you he hoped you would be able to do with your tests; isn't that right?
SHERRY CULHANE: Yeah, I assume so.
MR. BUTING: Okay. You also had some emails with Mr. Kratz, correct?
SHERRY CULHANE: Yes.
MR. BUTING: Actually, before we get to that, let me do one more here.
(Exhibit No. 342 marked for identification.)
MR. BUTING: I'm showing you Exhibit 342, would you be able to identify that for us?
SHERRY CULHANE: Yes.
MR. BUTING: That's another one of those case communication records?
SHERRY CULHANE: Yes.
MR. BUTING: But this one, though, is dated December 15th?
SHERRY CULHANE: Correct.
MR. BUTING: Concerns another phone conversation with Mr. Fassbender?
SHERRY CULHANE: Yes.
MR. BUTING: Mind if I put it up on the ELMO now?
MR. BUTING: This is, again, an incoming call where Mr. Fassbender is calling you, right?
SHERRY CULHANE: Yes.
MR. BUTING: Now, the first entry we should clarify a little bit, it says swab keys and collect swabs, no need to analyze at this time, right?
SHERRY CULHANE: Correct.
MR. BUTING: Just so we're not confused, the jury is not confused, that is not in reference to this Toyota key that was brought to you earlier, right?
SHERRY CULHANE: Correct.
MR. BUTING: That was a completely separate test that was done. This is some other keys that they brought to you?
SHERRY CULHANE: Yes, this was referencing some additional keys.
MR. BUTING: It also says, like a couple days later, four days later, that Mr. Fassbender wants you to swab handcuffs and leg irons, right?
SHERRY CULHANE: Yes.
MR. BUTING: As well as the license plates from the RAV 4 and to check the .22 caliber gun, Item DD, for any indication of the victim's blood on the barrel, right?
SHERRY CULHANE: Yes.
MR. BUTING: And also to swab the trigger guard area to compare with Steve Avery?
SHERRY CULHANE: Correct.
MR. BUTING: And we'll get into this with a little more detail with some of the other things first, but as long as we're at these phone messages, let me just clear this up. You did do that in this case, right?
SHERRY CULHANE: Yes.
MR. BUTING: You swabbed the handcuffs and the leg irons?
SHERRY CULHANE: Yes.
MR. BUTING: And you found no DNA of Teresa Halbach on those items, did you?
MR. BUTING: And you swabbed the license plates and you found no usable DNA that you could draw any conclusions from, right?
SHERRY CULHANE: Right.
MR. BUTING: And you checked the Item DD, .22 caliber gun, that's a rifle, right?
SHERRY CULHANE: Yes.
MR. BUTING: You looked for any blood of the victim on the barrel, right?
SHERRY CULHANE: Correct.
MR. BUTING: You found no DNA of Teresa Halbach on that barrel?
SHERRY CULHANE: Correct.
MR. BUTING: You looked at the trigger guard as well, not just the trigger guard, but the trigger itself?
SHERRY CULHANE: Yes.
MR. BUTING: You swabbed both, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you found no DNA of Mr. Avery, right?
SHERRY CULHANE: Correct.
MR. BUTING: Okay. And as to the handcuffs and leg irons, you did find some DNA on it, though, didn't you?
SHERRY CULHANE: Yes, I did.
MR. BUTING: You found Mr. Avery's own DNA?
SHERRY CULHANE: In a mixture sample, yes.
MR. BUTING: In a mixture with some other male, right?
SHERRY CULHANE: I can't tell for sure whether it was a male or a female.
MR. BUTING: Well, it wasn't a mixture with Teresa Halbach?
SHERRY CULHANE: Correct.
MR. BUTING: And the fact that you found DNA of any kind on the handcuffs, is an indication to you that they hadn't been wiped down with bleach, isn't it?
SHERRY CULHANE: That would be correct.
MR. BUTING: Okay. And you, of course, had no idea, way of knowing how old that DNA that you did find, from Mr. Avery, on those handcuffs or leg irons was, right?
SHERRY CULHANE: Right.
MR. BUTING: That's one thing about DNA, when you find a profile, you can't tell when it is -- or when it was originally deposited, correct?
SHERRY CULHANE: Yes, that's correct.
MR. BUTING: You find DNA sometimes in mummies thousands of years old.
SHERRY CULHANE: That's correct.
MR. BUTING: Okay. Now, I have used the term elimination samples today. I don't believe you used that term yesterday -- or Friday; do you recall?
SHERRY CULHANE: I don't recall.
MR. BUTING: With Mr. Gahn, you referred to samples as exemplars or reference samples, correct?
SHERRY CULHANE: Correct.
MR. BUTING: That's because the term elimination samples has a meaning behind it, that the others don't?
SHERRY CULHANE: That's correct.
MR. BUTING: Elimination sample is something that you refer to when you are just trying to eliminate somebody as a source?
SHERRY CULHANE: Correct. That would be -- excuse me -- that would be a situation where it was a case and perhaps you knew that someone's DNA was there ahead of time, and the elimination sample, for instance in a sexual assault case, and someone had consensual sex, then you would have an elimination standard from that consensual sex partner.
MR. BUTING: Right. So in that circumstance, there would be -- it's just sort of assumed, there's really no question or doubt, that the sample that you are looking at has nothing to do with the case?
SHERRY CULHANE: It just helps us sort that out if we find a mixture of DNA. An elimination sample would help us sort out who the possible contributors are.
MR. BUTING: Right. With the understanding that that person you are trying to eliminate is not a suspect?
SHERRY CULHANE: Correct.
MR. BUTING: Okay.
THE COURT: Very well, at this time we'll excuse the members of the jury for the Court to hear argument. Again, members of the jury do not discuss the case or any portion of the testimony you heard today, on your break. You are excused.
(Jury not present.).
THE COURT: You may be seated.
MR. BUTING: May I go ahead and mark this so we know what we're talking about. I will mark this one because it's not highlighted.
(Exhibit No. 343 marked for identification.)
MR. BUTING: Just by way of explanation, what I'm attempting to do at this point is show Ms Culhane an email that she received. I guess it's from Mr. Kratz. I do not intend to actually offer this into -- Well, I don't intend all the content of this email to come into this case, or to be sent to the jury, but I do wish one particular line of it where Mr. Kratz is telling the witness certain samples that he refers to as elimination samples. That's my only purpose. I don't know if counsel objects to that limited use.
THE COURT: Mr. Gahn.
MR. BUTING: I don't know if we need to send the witness out at this point. If there's any lengthy argument, we will otherwise.
THE COURT: I guess I'm anticipating the objection, if it's what I'm thinking it's going to be I don't know that it's necessary to send the witness out, but I will defer to the attorneys on that one.
MR. GAHN: Our position, your Honor, is that this email is dated February 7, 2006, and this is well after charges being brought in the Criminal Complaint against Mr. Avery. This is clearly work product on the part of Mr. Kratz. He's talking to his witness, Ms Culhane, and basically talking trial strategy, how to go about the case, testing certain exemplars, or items of evidence, and it's just clearly a work product.
MR. BUTING: Judge, first of all, if it is work product, that privilege is waived by turning it over in discovery, in my view. But I'm not really getting into work product. And I'm sensitive to that concern and I don't usually like to use emails in court at all. But here, I'm simply using it for one limited purpose, and that is her understanding of the characterization of specific samples as being elimination samples.
Those are Chuck, Earl, and Bobby. And that's really all I want to get into with this particular document.
THE COURT: Seems to me that point can be made without reference to this document.
MR. BUTING: If she can recall it and if she can say she's aware that they were described in those terms, sure, we can do that.
THE COURT: Does the State have any objection of letting the witness take a look at the email before she testifies and then we can bring the jury back in without introducing the email?
THE COURT: All right.
MR. GAHN: As long as Mr. Kratz is not going to be mentioned in your question that Chuck, Earl, and Earl's samples were -- could be considered elimination samples. That's all you want to say?
MR. BUTING: We could just say submitted by the State, whether it's police or prosecution is -- is not disclosed.
THE COURT: I may be wrong, but I thought there's been evidence already about elimination samples taken from other members of the Avery family. So I don't think the subject matter is a problem. And I don't see a need to phrase the question such that it would involve any attorney/client work product. So let's have the witness take a took at the email, if she needs it to refresh her memory, and I then think the question can be asked without suggesting that it involves a conversation with the attorneys.
All right. Mr. Buting, I think you can retrieve the document now, I believe the witness has reviewed it.
MR. BUTING: Okay. Are we ready to go?
MR. BUTING: No, this is all.
MR. BUTING: Sure. There are other items that I'm not going to introduce.
THE COURT: All right. Mr. Buting, do you want to retrieve the document you gave the witness.
MR. BUTING: Yes. And just so the record is clear, I'm not going to offer this as an exhibit. It's been marked, for the record, but this will be one of those where it's just part of the record, but it's not evidence in this trial.
THE COURT: Very well.
MR. BUTING: Is that fair? Okay.
(Jury present.)
THE COURT: You may be seated. Mr. Buting, you may continue.
MR. BUTING: Thank you, your Honor.
MR. BUTING: (By Attorney Buting)~ Now, Ms Culhane, you received a number of samples, not just Mr. Avery's, to compare the various pieces of possible evidence in the case, right?
SHERRY CULHANE: Correct.
MR. BUTING: And when you received a sample -- that is a DNA standard of Chuck Avery -- first let me establish that you did. You received an exemplar standard of Chuck Avery, Earl Avery, and Bobby Dassey, right?
SHERRY CULHANE: Yes.
MR. BUTING: Among some others?
SHERRY CULHANE: Yes.
MR. BUTING: Like the parents, Mr. and Mrs. Avery --
SHERRY CULHANE: Yes.
MR. BUTING: -- right? And when you received those samples, you were asked to do a profile for each of them, right?
SHERRY CULHANE: Yes.
MR. BUTING: And when you were asked to do a profile for each of them, those samples were referred to you as elimination standards, correct?
SHERRY CULHANE: Yes.
MR. BUTING: Which to your mind, and your understanding, would seem to indicate that you were not to consider any one of those three, Chuck, Earl, or Bobby, as suspects?
SHERRY CULHANE: That's not entirely correct. When I'm submitted a standard, it doesn't really matter if you call it an elimination standard, or a reference sample, if it fits the profile, the evidence sample, then it's reported on. If it's a match, it's reported on. Whether it's submitted as an elimination sample or as a reference standard, it's interpreted in exactly the same way.
So, if any of those elimination samples, or reference samples, are excluded, no matter what the evidence is, and no matter what you call them, then that's how it would be reported.
MR. BUTING: Sure. So if you get something that is told to you by the police as an elimination standard, and it hits, it matches some kind of crime scene evidence, you are going to report that, of course, right?
SHERRY CULHANE: Yes.
MR. BUTING: But the very fact that the items come to you with that designation, elimination standard, tells you something about what the police theory, or what they believe those samples relate to, whether they are a suspect or not?
SHERRY CULHANE: Correct.
MR. BUTING: Okay. Let me go back for a minute and talk about your background. I don't recall what exhibit it is that is your curriculum vitae, but I just want to clarify a few things. You have got a bachelor's degree in biological science; is that right?
SHERRY CULHANE: Yes.
MR. BUTING: And you actually went to two colleges, though. Your first college was Millsaps, M-i-l-l-s-a-p-s, College in Jackson, Mississippi?
SHERRY CULHANE: Yes.
MR. BUTING: You went there for just two years?
SHERRY CULHANE: Yes.
MR. BUTING: And then you transferred to Mississippi College to complete your undergraduate education, right?
SHERRY CULHANE: Correct.
MR. BUTING: Are you originally from that area, is that why you were going to school down there?
SHERRY CULHANE: Yes, I'm from Jackson.
MR. BUTING: Okay. And then you got your bachelor of science in 1978?
SHERRY CULHANE: Yes.
MR. BUTING: You did not go on and get a master's degree, right?
SHERRY CULHANE: Correct.
MR. BUTING: Never in all your years since, have you gone back to try and get a master's?
SHERRY CULHANE: That's correct.
MR. BUTING: I don't see anything in your CV that shows that you worked as a research scientist, right?
SHERRY CULHANE: No, I didn't.
MR. BUTING: You have little or no publications in the field?
SHERRY CULHANE: No, I have no publications.
MR. BUTING: Okay. And I don't see in here that you do any kind of public speaking, or teaching to other forensic scientists, outside of your own lab, in Wisconsin?
SHERRY CULHANE: Actually, I did present a paper at one of the Promega User's Meetings, because we were involved in the original validation of the Power Point 16 Kit. And I did present a paper at that meeting.
MR. BUTING: Okay. But that's the only time?
SHERRY CULHANE: That's correct.
MR. BUTING: And we'll talk a little bit more about validation in a few minutes. It's not really clear to me what jobs you had before you came to Wisconsin. Was it just working at the Jefferson Parish Sheriff's Office Crime Lab, or did you have some other employment between 1978 and 1984?
SHERRY CULHANE: No, I worked at the Jefferson Parish Crime Lab for two and a half, three years, I don't remember exactly, then I came to Wisconsin. And then after a year I was in Wisconsin, I was hired by the Crime Lab.
MR. BUTING: Okay. And now it's been 23 years that you have been on the job at the Wisconsin Crime Lab?
SHERRY CULHANE: That's correct.
MR. BUTING: And your current title is DNA Technical Unit Leader?
SHERRY CULHANE: Yes.
MR. BUTING: A position that you were appointed to in 1997?
SHERRY CULHANE: Yes.
MR. BUTING: Now, is that a position that requires -- Well, obviously, doesn't require a master's degree, right?
SHERRY CULHANE: Actually, it does. At the time -- time frame when I was appointed to this position, the DNA Advisory Board offered, was referred to as a waiver for individuals who had a certain amount of experience in forensics. In order to get that waiver, I had to go back to school and take molecular biology, statistics, and bio-chemistry classes, which were all at UW Madison or online.
MR. BUTING: Okay.
SHERRY CULHANE: So those requirements were filled. Now, anyone after a certain period of time, it does require a masters.
MR. BUTING: Okay. So you were sort of grandfathered in with this other way of getting some additional educational miles, right?
SHERRY CULHANE: Right. And because of my experience.
MR. BUTING: Okay. So it's kind of a seniority thing, too, because you have been there longer than most people?
SHERRY CULHANE: Because I have experience, that's correct.
MR. BUTING: Okay. Now, this current position as technical leader, you discussed as having some administrative duties, right?
SHERRY CULHANE: Yes.
MR. BUTING: And also some training duties?
SHERRY CULHANE: Yes.
MR. BUTING: And then, also, some actual DNA testing?
SHERRY CULHANE: Correct.
MR. BUTING: Can you tell me what percentage of your job involves each?
SHERRY CULHANE: Probably 70 percent is actual case work. The duties with training varies according to how many people we have in training. When everyone is trained and there are no new analysts, then I don't have any training responsibilities. But when we hire a new analyst, then I do spend a considerable amount of time training them. Overall, I would guess 70 percent is spent on case work.
MR. BUTING: So about 30 percent less case load, generally, than the other analysts?
SHERRY CULHANE: That's correct.
MR. BUTING: Okay. Let's talk about quality control, what you know about it in your lab, and just in general. You talked a lot about accreditation, right?
SHERRY CULHANE: Yes.
MR. BUTING: How important that is?
SHERRY CULHANE: Yes.
MR. BUTING: How rigorous the process is, right?
SHERRY CULHANE: Yes.
MR. BUTING: And one part of that is -- in fact, a big part of it, is these outside auditors, whatever you want to call them, outside overseers, look at the protocols that you are using to do certain tests, right?
SHERRY CULHANE: Yes.
MR. BUTING: And the -- there's various, I assume, accrediting type boards in different forensic fields?
SHERRY CULHANE: I believe there are several different accrediting institutions depending on what type of work. There's one for paternity testing. Most forensic labs have an ASCLD accreditation.
MR. BUTING: Okay. And certainly part of that is DNA protocols, right?
SHERRY CULHANE: Yes.
MR. BUTING: But more than that, it's also what other kind of test protocols your lab is following?
SHERRY CULHANE: Are you referring to other sections?
MR. BUTING: Yes, other sections.
SHERRY CULHANE: Yes, each section has their own protocols. And then we have lab-wide quality control standards that everyone follows, basically the same.
MR. BUTING: Okay. So, for instance, fingerprints, whatever that's called, identification division?
SHERRY CULHANE: Yes.
MR. BUTING: They have a specific protocol or number of steps they follow in order to come to a conclusion, right?
SHERRY CULHANE: Correct.
MR. BUTING: Ballistics the same way?
SHERRY CULHANE: Yes.
MR. BUTING: DNA, the same way?
SHERRY CULHANE: Yes.
MR. BUTING: And like trace -- let's say, one subsection of the trace division seems to be like volatile chemicals?
SHERRY CULHANE: I believe so.
MR. BUTING: So, in other words, there's -- in order for -- let's say someone comes -- brings in evidence from an arson, and the Crime Lab is asked to do these chemicals tests to determine whether there might be volatile chemicals like gasoline or something like that?
SHERRY CULHANE: I believe so.
MR. BUTING: Okay. And there's a protocol that they have to follow in order to do that test?
SHERRY CULHANE: Yes.
MR. BUTING: And these protocols are developed after a lengthy process, right?
SHERRY CULHANE: Correct.
MR. BUTING: They are peer reviewed?
SHERRY CULHANE: Yes.
MR. BUTING: And peer reviewed means that they are published so that other scientists, even in other parts of the country or world, can also try the same protocol and see if they get the same result?
SHERRY CULHANE: Yes.
MR. BUTING: They want to replicate, they want to be able to do the very same tests elsewhere and find that the results are valid and reliable?
SHERRY CULHANE: That's correct. And it also allows laboratories to compare results and exchange information.
MR. BUTING: Okay. And that's really -- that's part of the scientific process?
SHERRY CULHANE: Right.
MR. BUTING: Just in general, the whole idea that someone comes up with a theory, until it can be tested and repeated by others, it's just a theory, right?
SHERRY CULHANE: Yes.
MR. BUTING: And it becomes science after others have been able to test the theory over and over and replicate it, right?
SHERRY CULHANE: Yes.
MR. BUTING: And sometimes that can take years before something rises to the level where it's considered science in the community, right?
SHERRY CULHANE: That would be correct.
MR. BUTING: And that's true of protocols, a protocol is a plan, basically, a plan or method in which to test some item to get to a particular end result; would that be fair?
SHERRY CULHANE: Yes.
MR. BUTING: And those can take years, certainly months, sometimes years, to test over, and over, and over, to be sure that others can get the same results?
SHERRY CULHANE: Well, most of the time, when we're introducing a new protocol, it has been tested by -- like if the company that would provide the reagents and the equipment that we use to test it. And that would be a development validation.
In our laboratory, we don't necessarily go through a developmental validation, which would be more like research. We basically test it to make sure that it works in our laboratory. And that doesn't really take years.
MR. BUTING: Sure. But the development by the -- in your example was a reagent, or use of a reagent. But development by that chemical lab can take quite a while?
SHERRY CULHANE: Yes.
MR. BUTING: And you don't pick it up as something to use in your lab until it's already been -- until you are satisfied that it's been tested, retested, and it's a valid reagent.
SHERRY CULHANE: Correct.
MR. BUTING: Now, these audits you mention, these audits are something that are done for government labs as well as private labs, right?
SHERRY CULHANE: I believe so.
MR. BUTING: So, it's not like government labs are somehow exempt from the usual examination of auditors just because they are government, right?
SHERRY CULHANE: Right.
MR. BUTING: We don't just say, you know, we're the government, trust us?
SHERRY CULHANE: That's correct.
MR. BUTING: You guys have to prove your validity, your reliability, scientifically, like any other lab?
SHERRY CULHANE: Correct.
MR. BUTING: That's true of the Wisconsin State Crime Lab, right?
SHERRY CULHANE: Yes.
MR. BUTING: It's true of all government labs that you are aware of?
SHERRY CULHANE: If you're accredited -- We all have to follow the same rules if you are accredited by ASCLD.
MR. BUTING: Okay. And this whole accreditation process involves auditors at the very beginning getting the protocols, the test plans, and reviewing those before they ever get to your lab, right?
SHERRY CULHANE: That's correct.
MR. BUTING: And only then, if those protocols pass the peer review, at least that level of peer review from outside auditors, do they even take the next step of coming to your lab?
SHERRY CULHANE: Well, our protocols are set in place and they are given to the auditors so that they are familiar with our procedures before they come to the lab. And then, when they come to the lab, they verify that we're following our protocols.
MR. BUTING: So if you came up with a brand new protocol, never before done anywhere in the country, and you sent it off to these auditors and it had never been peer reviewed, what do you think they would say?
THE COURT: I'm going to sustain the objection. I think this might be more related to some other issue that doesn't involve this witness.
MR. BUTING: Well, I think this witness can testify, she's a scientist that was involved with quality control in her lab. I think I should be allowed to explore her understanding and knowledge of the development of protocols.
THE COURT: I don't think it's specifically related enough for the topic for which it's being introduced to be relevant, so I'm sustaining the objection.
MR. BUTING: (By Attorney Buting)~ Okay. Have you ever, in your lab, submitted a brand new protocol for a test that had never been done anywhere else in the country?
SHERRY CULHANE: I can only speak to what's been done in DNA. I don't have knowledge of any of the other sections or what they have done. In DNA, the protocols that we use have been peer reviewed and validated, developmental as well as the internal validation.
MR. BUTING: All right. And so you are comfortable with the protocols because of that.
SHERRY CULHANE: Yes.
MR. BUTING: And you would not submit a brand new protocol, never done before, for your DNA test, and expect to pass accreditation with that, would you?
THE COURT: Sustained.
MR. BUTING: (By Attorney Buting)~ All right. So let me move on a little bit. Your auditors come after they get the protocols and they check out the lab, right?
SHERRY CULHANE: Yes.
MR. BUTING: They check out the analysts, by way of proficiency tests?
SHERRY CULHANE: Correct.
MR. BUTING: And they also check out security and that whole process?
SHERRY CULHANE: Yes.
MR. BUTING: Like chain of custody?
SHERRY CULHANE: Correct.
MR. BUTING: Let's talk about that for a moment. Wisconsin's Crime Lab's chain of custody procedure, I believe you testified the agency submits it, usually police, bring it into your lab, some central gathering person, right?
SHERRY CULHANE: Yes.
MR. BUTING: What do you call them?
SHERRY CULHANE: We have three evidence specialists.
MR. BUTING: And what they do is, they look at the evidence. You said they make sure it's sealed, right?
SHERRY CULHANE: Yes.
MR. BUTING: They give it one of these numbers, or you call them numbers but they are often letters, right?
SHERRY CULHANE: Well, a lab number refers to the whole case, and then an item designation and a letter.
MR. BUTING: Okay. So the lab number in this case is -- well, I don't expect you to have it memorized, but it's M05-2467.
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Then you do have it memorized. And then as the items come in they get named, or designated, item A, B, C, all the way through the alphabet?
SHERRY CULHANE: Right.
MR. BUTING: Then they start getting called AA, AB, AC all the way through the alphabet that way?
SHERRY CULHANE: Yes.
MR. BUTING: Where do they go after that, B?
MR. BUTING: BB, BC, BD, and you keep on going.
SHERRY CULHANE: Right.
MR. BUTING: And in this case, probably you got higher designations than any other case that's ever come to your lab?
SHERRY CULHANE: I believe that's correct.
MR. BUTING: Three hundred fifty you said, right?
SHERRY CULHANE: About that, yes.
MR. BUTING: And when that happens, when it first comes in, this evidence specialist not only gives it a designation, but then fills out some kind of form that verifies the evidence has come into the lab, right?
SHERRY CULHANE: Yes.
MR. BUTING: And at the end of the case, or whatever, at whatever point your lab decides to send the evidence back to the submitting agency, they submit another -- or fill out another form, right?
SHERRY CULHANE: Yes.
MR. BUTING: And that form is called an Evidence Release Return Form?
SHERRY CULHANE: Yes.
THE COURT: All right. Members of the jury, I think what I will do at this time is excuse you for your morning break. And we'll resume with testimony after the break is complete. I will remind you, again, not to discuss this matter during the break. Jury is excused.
(Jury not present.)
THE COURT: You may be seated.
MR. BUTING: Excuse the witness, please.
THE COURT: I'm going to excuse the witness right now. You are excused. Mr. Gahn.
MR. GAHN: Your Honor, Mr. Buting has presented a form here from the -- used by the Crime Lab. It's an Evidence Release Return Form. But, again, I guess I would like to see an offer of proof of where are we going with this 1985 case. This had to do with the 1985 case, when that evidence was returned, to whom it was returned, and I just fail to see the relevancy of going down this road at this point.
THE COURT: Can somebody give me a copy of the offered exhibit?
MR. BUTING: Should I mark it?
THE COURT: I think we should mark it.
MR. GAHN: My understanding, your Honor, is they have stated their defense, it's this planting of the blood vial. And this has nothing to do with the blood vial, or anything remotely connected.
MR. BUTING: Judge, what it is is a record regularly kept in the course of her business. She's going to be able to easily identify it. She's talked about the 2003 exoneration. It shows that Mr. Avery's buccal swabs --
THE COURT: Is your microphone on?
MR. BUTING: Yes. It shows that Mr. Avery's buccal swabs, that used to be in the custody of the Crime Lab, were sent back to the Manitowoc County Sheriff's Department in 2003.
THE COURT: All right. I had understood that the blood that was in the Clerk's Office was going to be the subject of the defense. How does this exhibit relate to that defense?
MR. BUTING: Well, this witness has testified that there's DNA found on items that she said she didn't see any blood, which could have come from buccal swabs. So she's already testified to that, so it's in play, whether or not the Manitowoc Sheriff's Department had any of Mr. Avery's DNA in another form, which they did.
THE COURT: Do we know if these items, which on their face at least, say they are sealed, are still sealed somewhere in the Sheriff's Department Office?
MR. BUTING: That would be the subject of testimony later, I suspect. But at this point, all I'm doing is showing that they are not still at the Crime Lab, that they were sent back to the submitting agency, in this case, Detective Remiker.
THE COURT: Mr. Gahn.
MR. GAHN: Well, your Honor, I guess I don't understand what's happening here. Is -- Now, are we switching that the planting did not come from the blood, but the planting now came from the buccal swabs of Steven Avery? Is that what the defense is stating now? Are they switching and changing their theory of defense, that it's no longer from the blood vial that's in the Clerk's Office, but now the planting took place with buccal swabs of Steven Avery? Now this is new --
MR. BUTING: Judge, this is not new. We have alleged -- Look, they brought up, on direct, that there was DNA that she discovered that she said did not appear to come from blood. So it had to come from another source. This is another source, that according to this record at least, was sent back to Manitowoc County Sheriff's Department. And we will tie it up later when we establish that it is in fact still in the Manitowoc Sheriff's Department, or at least it was as of October -- or November 5th, whatever, 2005.
MR. GAHN: Your Honor, I guess their offer of proof in this case, which the Court required, and in their offer of proof, it was the planting was done by the blood vial. Simple as that. That was it. Now they are going off on this buccal swab now, that the planting may have come from there. And I don't --
MR. BUTING: Judge, I don't mean to cut counsel off, but it is in response to testimony they elicited here, that some of it, some of the DNA apparently did not come from blood. Now, we have a right to respond to that and this is a response. It is not an explanation for the blood in the RAV 4.
THE COURT: Right.
MR. BUTING: Maybe an explanation for some of the other.
THE COURT: My recollection is that the previous contested hearing involved the blood vial. I don't know that I was asked to rule on anything other than the vial. I believe the evidence first came up at that point, that there was some DNA evidence of Mr. Avery, apparently not from blood, that was found, if I recall correctly, on the Toyota key and on the hood latch.
And so I don't think I can say that this exhibit would not be relevant. The State is free to show in rebuttal or as part of it's case-in-chief that these samples are still sealed somewhere in the Sheriff's Office. I think it is relevant. So after we get back from our break, I will allow the defense to pursue this matter.
MR. BUTING: Thank you. What time did you say?
THE COURT: Let's come back in 15 minutes.
MR. BUTING: All right. Thank you.
(Recess taken.)
(Jury present.)
THE COURT: At this time the witness can be brought back into the courtroom. Attorney Buting, you may resume.
MR. BUTING: Thank you, your Honor.
CROSS-EXAMINATION CONTD. BY ATTORNEY BUTING:
MR. BUTING: Now, Ms Culhane, we were talking about, before the break, about this process that you go through when -- your lab goes through when evidence is brought in from the agency and, actually, also, when it's returned to the agency, correct?
SHERRY CULHANE: Yes.
MR. BUTING: I'm showing you Exhibit 344, can you identify that?
SHERRY CULHANE: Yes, this is a copy of our -- the forms that we fill out when we send evidence back to the agency.
MR. BUTING: Okay. And this is a regular record that's used by your lab in the course of business, day-to-day?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. And it's meant, as part of a chain of custody, to document where evidence goes, who has it at any given time?
SHERRY CULHANE: Right.
MR. BUTING: When you're done with it, you want to make sure it's clear you are done with it, it is no longer your responsibility, from that point on?
SHERRY CULHANE: Right.
MR. BUTING: All right. I'm just going to put up here, on the ELMO, Exhibit 344. And this has a case number on it, rather old case number, right?
SHERRY CULHANE: Yes, that's actually the agency number. I would recognize it by our lab number, which is on the other side.
MR. BUTING: I'm sorry, let's move over here.
SHERRY CULHANE: There you go.
MR. BUTING: And the 85 -- M85, 85 refers to the year of the case that it's submitted to you?
SHERRY CULHANE: Yes.
MR. BUTING: So that would be 1985?
SHERRY CULHANE: Yes.
MR. BUTING: So this is actually an Evidence Release Form relating to Mr. Avery's 1985 conviction, right?
SHERRY CULHANE: Correct.
MR. BUTING: And the last item number, W, designated W, at the bottom there, says one sealed envelope containing -- I always call it buccal, is it buccal?
SHERRY CULHANE: Buccal.
MR. BUTING: Buccal. Containing buccal swabs reportedly recovered from Steven Avery, right?
SHERRY CULHANE: Yes.
MR. BUTING: And by this form, what you are saying is that -- moving it to show the date here -- the date is October 13th of 2003, right.
SHERRY CULHANE: Could you slide it over just a little bit?
MR. BUTING: Sure. Let me zoom out of it, maybe we can see. Does that help?
SHERRY CULHANE: Yeah. It was released from our lab on September 25th, 2003.
MR. BUTING: Okay.
SHERRY CULHANE: And it was signed for at Manitowoc Sheriff's Department on 10/13/03?
MR. BUTING: And the name of the person who is signing it is Detective Remiker, or Dave Remiker?
SHERRY CULHANE: It appears to be.
MR. BUTING: Manitowoc Sheriff's Department, right?
SHERRY CULHANE: Yes.
MR. BUTING: That's the printed name and then there's a signature next to it, which I assume you can't identify yourself?
MR. BUTING: Do you know Mr. Remiker?
MR. BUTING: Okay. So, what this document tells you, then, is that on -- in September of 2003, you returned Mr. Avery's buccal swab reference sample to the Manitowoc County Sheriff's Department?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, back to the internal chain of custody. When the evidence first comes in to this evidence specialist; we saw a name up there, Sue Glitchel, I think it was?
SHERRY CULHANE: Gitchel, yes.
MR. BUTING: G-l-i --
SHERRY CULHANE: G-i-t-c-h-e-l.
MR. BUTING: G-i-t-c-h-e-l. Fran Lutz is another one?
SHERRY CULHANE: Mm-hmm.
MR. BUTING: L-u-t-z?
SHERRY CULHANE: Yes.
MR. BUTING: Anyway, they take it and they put it in some sort of communal storage room; is that what happens?
SHERRY CULHANE: Yes.
MR. BUTING: And that's a locked room?
SHERRY CULHANE: Yes.
MR. BUTING: That only certain people can come and go?
SHERRY CULHANE: That's correct.
MR. BUTING: Those people include the individual DNA analysts, right?
MR. BUTING: No?
SHERRY CULHANE: No, it's only evidence specialists, the supervisors, and our director.
MR. BUTING: So when you need to go work on something that's a part of evidence that's been brought in, you have to go check in with the evidence custodian?
SHERRY CULHANE: Yes. And we request evidence and then they bring it to -- there's a window there, they bring it to us, and then we take custody of it.
MR. BUTING: Okay. And somewhere it's marked that you now have custody of it, rather than the central storage?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. And then when you take it, you or any of the analysts take it into your possession, you bring it over to your lab bench?
SHERRY CULHANE: Yes.
MR. BUTING: Do you have some sort of storage lockers there?
SHERRY CULHANE: Yes, in the front part of our lab bench.
MR. BUTING: And can you just describe what those are, what they look like?
SHERRY CULHANE: The front of our lab bench, they are probably about this deep and maybe, I don't know, 3, 6 feet long. And they have shelves in them.
MR. BUTING: The lab benches are about 6 feet long?
SHERRY CULHANE: Well, I don't remember. There's shelving inside there and they are on the front of our lab bench where we do our work space. And then on the front we have cabinets that we can put evidence in.
MR. BUTING: Okay. And is there more than one on each bench?
SHERRY CULHANE: The benches in the lab are T-shaped. There's one analyst on each side. I have -- Each analyst has two cupboards for storage.
MR. BUTING: Okay. When you say cupboards for storage, these are like drawers?
SHERRY CULHANE: No, you just open the door and there's shelving.
MR. BUTING: Okay. There's shelves underneath the bench you are actually working on?
SHERRY CULHANE: Yes.
MR. BUTING: That's the lab bench where you are doing certain tests?
SHERRY CULHANE: Yes.
MR. BUTING: Extractions usually?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. And are these cupboards or these shelves you are talking about, are they -- they have doors on them?
SHERRY CULHANE: Yes.
MR. BUTING: Are they like open wire mesh kind of doors?
SHERRY CULHANE: No, they are regular locked wooden doors.
MR. BUTING: Solid doors?
SHERRY CULHANE: Yes.
MR. BUTING: And they have locks on them?
SHERRY CULHANE: Yes.
MR. BUTING: And there's two separate shelves, or two separate cupboards?
SHERRY CULHANE: There's two shelves in each cupboard and there's two separate cupboards.
MR. BUTING: Okay. And each analyst has two of those?
SHERRY CULHANE: Yes.
MR. BUTING: And that's so that if you are working on one big case, you don't mix up the items from that case with some other case you are working on?
SHERRY CULHANE: Yes, it's just storage space for evidence that's being worked.
MR. BUTING: So you wouldn't mix one case -- evidence from one case that you are working and put it in the same cupboard with another?
SHERRY CULHANE: No. We do store several cases, but the cases are -- the items of evidence within the case are packaged and sealed.
MR. BUTING: Sure. All right. So you -- you do try and keep the evidence from one case all together?
SHERRY CULHANE: We try, yes. But we have several cases in that area at the same time.
MR. BUTING: Okay. And so in this case, when you would be working on any of the evidence in this case, you would try and keep all of the evidence that's not up on the bench, you would try and keep it all in one cupboard?
SHERRY CULHANE: Yes.
MR. BUTING: All right. And is the key that only you have to the cupboard, or do all the analysts keys work on the same cupboard?
SHERRY CULHANE: All the analysts have a key.
MR. BUTING: And the key works for all of these cupboards?
SHERRY CULHANE: Yes.
MR. BUTING: So you could open up someone else's cupboard?
SHERRY CULHANE: Yes.
MR. BUTING: Or they could open up yours?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Not that you would want to, but I'm just trying to establish that for the record?
SHERRY CULHANE: Right.
MR. BUTING: Now, when you take evidence out of your cupboard and start working it on your bench, is it always put back at the end of the day and locked in the cupboard?
MR. BUTING: Sometimes you have tests and things that work overnight, right?
SHERRY CULHANE: Yes.
MR. BUTING: All right. Now, in this case, you worked a little bit differently with regard to the RAV 4 stains, because you are the one who actually took them in?
SHERRY CULHANE: That's correct.
MR. BUTING: So instead of the police department delivering swabs of these stains, that you would then check out from the evidence custodian, it didn't work that way?
SHERRY CULHANE: Right.
MR. BUTING: What happened was, on November 7th, I believe?
SHERRY CULHANE: Yes.
MR. BUTING: Monday, you come down to the garage and you see there's this RAV 4 there, Toyota RAV 4?
SHERRY CULHANE: Right.
MR. BUTING: And you are there after Mr. Groffy, right?
SHERRY CULHANE: Yes.
MR. BUTING: He's already done his photographs and processing before you ever touch it?
SHERRY CULHANE: Right.
MR. BUTING: And you testified that you took a number of those swabs, a number of stain swabs. You mentioned a -- I forget what the last number -- actually the last number was A-23, right?
SHERRY CULHANE: I believe so, yeah.
MR. BUTING: So you actually took 23 swabs in different areas, some of them the same areas?
SHERRY CULHANE: No. I only took -- someone else was processing it for ident, I believe. And that's where the 23, I didn't take 23 swabs.
MR. BUTING: I see what you are saying. So what you are saying is, you took A-1, A-2, A-3, A-4, up to where, 12?
SHERRY CULHANE: A-12, I believe.
MR. BUTING: Okay. And then Mr. Riddle, Michael Riddle?
SHERRY CULHANE: Yes.
MR. BUTING: He's the fingerprint guy?
SHERRY CULHANE: Right.
MR. BUTING: He examined it. And when he would find fingerprints on it, he would give those a designation like A-13 or A-14.
SHERRY CULHANE: Right. Actually, I worked up through A-14.
MR. BUTING: Okay. And then there is a stain, a swab that you took, though, that's designated A-23?
SHERRY CULHANE: Correct.
MR. BUTING: And that's because Mr. Riddle found something he thought maybe you should take a look at and swab.
SHERRY CULHANE: Yes.
MR. BUTING: So Mr. Riddle found something, fingerprints or whatever, that he designated A-15 through A-22?
SHERRY CULHANE: I assume so.
MR. BUTING: Okay. And you came in and did this last one?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. And then you took all these swabs, you said they were in like a test tube holder, to dry?
SHERRY CULHANE: Yes.
MR. BUTING: Did you package them there at the bench in the garage, or did you take it back to your department, your bench, to package?
SHERRY CULHANE: I believe I packaged them in the garage.
MR. BUTING: So they were dry already?
SHERRY CULHANE: No, I put them in the coin envelope and I left the envelope open.
MR. BUTING: Okay. And these swabs, just so we're clear, they're like Q-tips?
SHERRY CULHANE: Yes.
MR. BUTING: Longer?
SHERRY CULHANE: Essentially, yes.
MR. BUTING: Okay. So then you took the swabs that you found from the RAV 4, the 14, and you brought them directly to your lab bench?
SHERRY CULHANE: Yes.
MR. BUTING: And then into your storage locker?
SHERRY CULHANE: Actually, they were on my lab bench while they air dried -- or they were in the coin envelopes on my lab bench, overnight, while they air dried.
MR. BUTING: Okay. And, then, once they were dried and you were -- Well, you did some tests with them, I'm sure. But once you were done with doing those first round of tests in November, you put them in your storage locker?
SHERRY CULHANE: Yes, they were sealed up and put away.
MR. BUTING: You didn't return them or place them in central storage?
SHERRY CULHANE: I can look. I don't recall exactly when I --
MR. BUTING: Why don't you look. Why don't you look at -- you have the Chain of Custody Report?
SHERRY CULHANE: Yes.
MR. BUTING: Look at Page 1 of 50?
SHERRY CULHANE: I'm sorry, what items?
MR. BUTING: It's the Chain of Custody Report, just look at the first page.
SHERRY CULHANE: Okay.
MR. BUTING: First page lists A, A-1, 2, 3, 4, 5 -- I'm sorry, 4-A.
SHERRY CULHANE: Yes.
MR. BUTING: Right?
SHERRY CULHANE: Right.
MR. BUTING: And A-1, A-2, A-3, were all determined to be Teresa Halbach's DNA, if you recall?
SHERRY CULHANE: That's correct.
MR. BUTING: Those were the swabs from the blood in the back, and the rear of the cargo?
SHERRY CULHANE: And four.
MR. BUTING: And four as well. Okay.
SHERRY CULHANE: Yes.
MR. BUTING: And those were in your custody until when?
SHERRY CULHANE: April 3rd, 2006.
MR. BUTING: Okay. And so, then, on that date, you returned them to the central storage area with the evidence specialist?
SHERRY CULHANE: Correct.
MR. BUTING: But from November up to April 3rd, they were sitting in your storage area of your lab bench?
SHERRY CULHANE: Sealed, yes.
MR. BUTING: Yes. But in that same compartment all together?
SHERRY CULHANE: That's correct.
MR. BUTING: With whatever other evidence you had on the Avery case, all in that same cupboard, right?
SHERRY CULHANE: Correct.
MR. BUTING: Okay. Then, if you look ahead maybe to Page 38 of your Chain of Custody Report, directing your attention to Item FL as in Larry, FL?
SHERRY CULHANE: Yes.
MR. BUTING: Now, you previously testified about that, that's the bullet fragment?
SHERRY CULHANE: Yes.
MR. BUTING: Right?
SHERRY CULHANE: Yes.
MR. BUTING: That's the one that you say you found Teresa Halbach's DNA on?
SHERRY CULHANE: Correct.
MR. BUTING: That came into your lab on what date?
SHERRY CULHANE: March 16, 2006.
MR. BUTING: And it came into your custody from that central room on what date?
SHERRY CULHANE: March 28, 2006.
MR. BUTING: Okay. And then you actually started working on it the next day, March 29th; isn't that right? Do you need to refer to your case notes?
SHERRY CULHANE: Yes, I do.
MR. BUTING: That's fine.
SHERRY CULHANE: I began -- I began -- I screened the evidence on March 29th, '06.
MR. BUTING: Okay. And, then, one of the things you do in that -- first thing is you open it up and take a look at it, right?
SHERRY CULHANE: Yes.
MR. BUTING: You unseal the -- whatever it is, and in this case it was like a little plastic bag, right?
SHERRY CULHANE: Right.
MR. BUTING: And you then began -- we'll talk about it more later, but at that point you began the process of extraction amplification and, ultimately, figuring out a profile?
SHERRY CULHANE: Yes.
MR. BUTING: And that's the test that we later -- we heard later, at some point in the process, was contaminated with your DNA?
SHERRY CULHANE: That's correct.
MR. BUTING: Proficiency tests are something that you take about every year or so?
SHERRY CULHANE: Twice a year.
MR. BUTING: Twice a year. And they involve you doing -- testing a sample that's sent to you by some outside private company?
SHERRY CULHANE: Yes.
MR. BUTING: And those are just pass/fail, right?
MR. BUTING: You get a grade, A, B, C?
SHERRY CULHANE: Well, you -- I suppose they are pass/fail, but it's not -- you are required to put the types down and they are -- also you are required to actually record the types that you develop and then there are several interpretation questions on there. Could the sample contribute to this evidence sample? Could the sample from the victim contribute to the evidence sample? So we actually have to record our types and do some interpretation.
(Exhibit No. 345 marked for identification.)
MR. BUTING: I'm showing you now Exhibit 345, can you identify that for the record?
SHERRY CULHANE: Yes. This is a copy of the -- Once we sent our answers back to the company, then they send us documentation as to whether our types are consistent with the types that should be on the case --
MR. BUTING: All right.
SHERRY CULHANE: -- test.
MR. BUTING: And, then, this actual report that you have in your hand is something that's filled out by supervisors in your lab?
SHERRY CULHANE: Well, yes.
MR. BUTING: Okay. That report isn't prepared by this outside company, that's prepared by someone in your lab, right?
SHERRY CULHANE: Yes.
MR. BUTING: And on this particular one, it has a number of boxes -- in fact, they all have a number of boxes where they say -- well, let's look at the main ones. Technical performance on this one was accepted, right?
SHERRY CULHANE: Right.
MR. BUTING: But on this particular one, it also has some comments. What does that mean? What are the comments on this?
SHERRY CULHANE: I'm not sure. I don't recall that test, so I really -- I'm not sure what is meant by that.
MR. BUTING: Let's look at the date for a minute. The date is April 7th of '06?
SHERRY CULHANE: Correct.
MR. BUTING: Actually, if you look up here, the test is -- looks like you completed the test on March 1st?
SHERRY CULHANE: Yes.
MR. BUTING: And then it was received -- compilation received by the a lab or something on --
SHERRY CULHANE: Yes.
MR. BUTING: -- on April 4th?
SHERRY CULHANE: Yes.
MR. BUTING: So this is really right about the time that you are doing this test on the alleged bullet fragment in Mr. Avery's case, right?
SHERRY CULHANE: Yes.
MR. BUTING: And often these results or comment sections are blank. They don't say anything. They just check acceptable or not acceptable, right?
SHERRY CULHANE: Sometimes. Sometimes there's a comment.
MR. BUTING: And this one indicates some what, a mistake that you made?
SHERRY CULHANE: I don't believe so, no.
MR. BUTING: It's referring to a non-sperm fraction with a mixture of victim and semen donor is what that says.
SHERRY CULHANE: Like I said, I can't really comment because I don't remember the specific proficiency test.
MR. BUTING: And that's not your handwriting?
MR. BUTING: But it is your -- also your supervisor's signature at the bottom?
SHERRY CULHANE: Yes.
MR. BUTING: And your signature on April 10th of '06?
SHERRY CULHANE: Right.
MR. BUTING: Okay. But you don't ever recall seeing this?
SHERRY CULHANE: Well, obviously I saw it, because I signed it.
MR. BUTING: Sure.
SHERRY CULHANE: But, no, I don't independently recall.
MR. BUTING: Okay. Would it be fair to say that the Wisconsin Crime Lab has a pretty heavy case load of DNA, your section, the DNA unit?
SHERRY CULHANE: Yes.
MR. BUTING: You have gotten a lot of publicity about it lately?
SHERRY CULHANE: Yes.
MR. BUTING: Became an issue in the last election for the Attorney General for the State of Wisconsin, right?
SHERRY CULHANE: Apparently.
MR. BUTING: Well, you were in the lab and you are part of management to some degree, right?
SHERRY CULHANE: Not really. I'm not really part of management. I have some management duties, but I'm not really considered management.
MR. BUTING: Okay. But part of those duties are case work, case flow, and case management?
SHERRY CULHANE: Right.
MR. BUTING: And priority, right?
SHERRY CULHANE: Yes.
MR. BUTING: So you are certainly aware that the case load has been going up, and up, and up, at the Crime Lab?
SHERRY CULHANE: Yes.
MR. BUTING: And that you are getting calls from prosecutors and police all the time, asking you to, please, do these -- get these results in yesterday?
SHERRY CULHANE: Correct.
MR. BUTING: They want them fast?
SHERRY CULHANE: Yes.
MR. BUTING: And so there's some pressure on the analyst to get the job done?
SHERRY CULHANE: Of course.
MR. BUTING: Okay. And that's important for a number of reasons, for instance, you don't want a suspect in a case, who's DNA has already been sent to you, to be out running around committing new crimes, when if you can get to your tests quicker, you might be able to link him to something and get him off the streets?
SHERRY CULHANE: That's correct.
MR. BUTING: It's also important, because you do some post-conviction tests as well?
SHERRY CULHANE: Yes.
MR. BUTING: And you don't want an innocent man sitting in prison longer than necessary, while his DNA sample sits in your office, unanalyzed, because of backlog?
SHERRY CULHANE: Correct.
MR. BUTING: And just to give the jury some estimate or some understanding of the numbers here, correct me if I'm wrong, but my understanding is that your -- the DNA Unit's backlog of work, approximately tripled between 2003 and 2005; would that be about right?
SHERRY CULHANE: I believe that's right.
MR. BUTING: If I gave you the number that your backlog of cases that you were working on in 2003 was 478, and as of 2005 it had gone to 1,375; does that sound about right?
SHERRY CULHANE: I don't remember the exact numbers, but when you are talking about DNA cases, you are talking about the Madison Lab and the Milwaukee Lab.
MR. BUTING: Sure.
SHERRY CULHANE: So, we're not just talking about one laboratory. And if those numbers were what was quoted, I assume that's correct. I don't recall exactly.
MR. BUTING: So when Mr. Avery's case came to your lab, it came to your lab at a time when there was already this huge backlog that had just ballooned or exploded over the last two years, or tripled?
SHERRY CULHANE: That's correct.
MR. BUTING: This case, then, put an enormous demand on your resources, right?
SHERRY CULHANE: Yes.
MR. BUTING: Three hundred and fifty submissions to the overall Crime Lab, all the different sections, right?
SHERRY CULHANE: Correct.
MR. BUTING: One hundred eighty just to the DNA Unit?
SHERRY CULHANE: That's correct.
MR. BUTING: And so while all these -- while these 180 pieces of evidence were in your lab to be analyzed in the Avery case, your analysts were also working very hard to reduce that backlog and deal with all the other submissions that kept coming in?
SHERRY CULHANE: That's correct.
MR. BUTING: Would you agree that there was, given the case load, there was a shortage of analysts, in 2005, in your lab?
SHERRY CULHANE: Yes.
MR. BUTING: The Madison Lab?
SHERRY CULHANE: Yes.
MR. BUTING: And that you were trying to bring new ones on board, that's part of the idea was to -- your function, was to help train new people?
SHERRY CULHANE: That's correct.
MR. BUTING: But you said that takes some time, nearly a year, to train somebody new, right?
SHERRY CULHANE: Right.
MR. BUTING: And the way you trained them, let's talk about 2005 and 2006, you had a number of new analysts that were sort of under your wings, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you would train them by -- kind of like you see on doctor shows, where you have the main doctor and the interns following along, right, like ducklings?
SHERRY CULHANE: Sure.
MR. BUTING: They follow you around to wherever you go?
SHERRY CULHANE: Part of their training --
MR. BUTING: Okay.
SHERRY CULHANE: -- involved that.
MR. BUTING: And part of that training would mean they would follow you when you went up to your lab bench to do something?
SHERRY CULHANE: Sometimes.
MR. BUTING: Okay.
SHERRY CULHANE: Not that often. Most -- A lot of their training revolves around lectures, and reading, and running their own samples. And some of the trainees in this case were coming from other laboratories, so they had quite a bit of training already. So it wasn't totally following me around.
MR. BUTING: All right. But there were some -- certainly some aspects of the training that required them, these trainees, to be with you when you are actually doing tests at your lab bench?
SHERRY CULHANE: Yes.
MR. BUTING: And so you could demonstrate for them how to do it, right?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, that means, however, that there were more people than usual surrounded around a lab bench when you are doing your tests?
SHERRY CULHANE: Yes, on a limited basis.
MR. BUTING: Sure. You try and limit it, and you are not trying to contaminate anything, of course, right?
SHERRY CULHANE: Right.
MR. BUTING: But the more people around an evidence bench, or lab bench with evidence on it, the greater the risk of contamination, right?
SHERRY CULHANE: Yes.
MR. BUTING: Did you ever have any trainee actually do a hands on test in this case?
MR. BUTING: Even under your supervision?
MR. BUTING: You did it all?
SHERRY CULHANE: Yes.
MR. BUTING: And they just watched?
SHERRY CULHANE: Yes.
MR. BUTING: And that was especially true on the day that you were testing the bullet?
SHERRY CULHANE: Yes.
MR. BUTING: Item FL?
SHERRY CULHANE: Yes.
MR. BUTING: The trainee's were around you.
SHERRY CULHANE: Well, there were two -- two trainees sitting by my work space watching the beginning portion of the extraction.
MR. BUTING: Okay. We'll talk more about that in a moment. All right. I apologize for the delay. I'm going to show you what's marked Exhibit 308 and 307. Just take a moment to orient yourself.
SHERRY CULHANE: Okay.
MR. BUTING: Okay.
SHERRY CULHANE: Mm-hmm.
MR. BUTING: Let me put these up on the screen. Tell me what these are pictures of. Can you tell me what this Item 307 is a picture of?
SHERRY CULHANE: That's the rear of the RAV 4, our item A.
MR. BUTING: Okay. And that is in the Crime Lab garage?
SHERRY CULHANE: Yes.
MR. BUTING: And you recognize the location?
SHERRY CULHANE: Yes.
MR. BUTING: And this particular photograph shows the rear of the RAV 4, with the wheel cover and the cargo door, right?
SHERRY CULHANE: Yes.
MR. BUTING: And if I zoom in on this a little bit, does this depict the door handle for the tailgate, or whatever you want to call it, the rear door?
SHERRY CULHANE: Yes.
MR. BUTING: Cargo door. That's the area that Mr. Riddle was working on for fingerprints, correct?
SHERRY CULHANE: I believe so, yes.
MR. BUTING: And that's the area where he said, hey, maybe -- there's something here maybe you want to take a look at that?
SHERRY CULHANE: Yes.
MR. BUTING: That's the item, then, that became A-23?
SHERRY CULHANE: Yes.
MR. BUTING: And you tested that, with a swab, for DNA, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you did not find Mr. Avery's DNA on that swab, did you?
MR. BUTING: And, so, if Mr. Kratz, in his opening statement, told this jury, with a power point slide, right up here showing that, with the circle around that rear door, and said that that would -- there would be evidence that Mr. Avery's DNA was on that door handle, that would be wrong, wouldn't it?
SHERRY CULHANE: Based on my results, I didn't find Steven Avery's DNA on that sample.
MR. BUTING: In fact, you found Mr. Avery's DNA nowhere on the rear of that vehicle at all, correct?
SHERRY CULHANE: Correct.
MR. BUTING: Even more so, you never found Mr. Avery's DNA anywhere around the outside of any of the door handles of that vehicle, did you?
SHERRY CULHANE: No. But I -- I didn't test any of the exterior doors.
MR. BUTING: And you later received some swabs of the interior door handles, didn't you?
SHERRY CULHANE: Yes.
MR. BUTING: And you did not find Mr. Avery's DNA on that, did you?
MR. BUTING: You found Teresa Halbach's DNA on at least one of them, right?
SHERRY CULHANE: Right.
MR. BUTING: You testified, though, to finding six apparent blood stains, and all of them were, essentially, in the passenger compartment area. This is in November we're talking about. Okay.
SHERRY CULHANE: Mm-hmm.
MR. BUTING: All of those were in that passenger compartment area of the RAV 4, right?
SHERRY CULHANE: Exactly which ones are you referring to, because there were several -- there were stains throughout the car.
MR. BUTING: Sure. And that's why I want to get clear.
SHERRY CULHANE: Okay.
MR. BUTING: Would you go to your -- Do you have some handwritten notes of --
SHERRY CULHANE: Yes, I do.
MR. BUTING: -- where you found those stains on November 7th?
SHERRY CULHANE: Yes.
MR. BUTING: You want to take a moment and refresh your recollection on those.
SHERRY CULHANE: Are we talking about stains throughout the car, or stains consistent with each individual, or -- I'm not sure what your question is.
MR. BUTING: Let's talk about the stains that you say your tests showed were Mr. Avery's DNA, or had Mr. Avery's DNA on them?
SHERRY CULHANE: Okay.
MR. BUTING: You found them several places in the driver's seat?
SHERRY CULHANE: Yes.
MR. BUTING: And the ignition on the dash?
SHERRY CULHANE: Yes.
MR. BUTING: And the seat right next to the driver's seat, the front passenger seat, right?
SHERRY CULHANE: Yes.
MR. BUTING: And then you found one in the rear passenger door, on the right side, as you open the door. There's a little ledge.
SHERRY CULHANE: Panel, yes.
MR. BUTING: Okay. But you found none of Mr. Avery's DNA on any stains in the rear cargo area of that vehicle, did you?
MR. BUTING: None on the outside handle of the cargo door?
SHERRY CULHANE: That's correct.
MR. BUTING: None on the inside handle of the cargo door?
SHERRY CULHANE: Correct.
MR. BUTING: And, in fact, where you found those six stains in November, of 2005, November 7th --
SHERRY CULHANE: Yes.
MR. BUTING: -- the ones that were attributed later, to Mr. Avery's DNA, one could have planted simply by opening two doors in that vehicle?
SHERRY CULHANE: I really can't comment on that.
MR. BUTING: Okay. You have got -- if someone was to plant Mr. Avery's blood in that vehicle, to get to those six stains, they would need to open the driver's door, right?
SHERRY CULHANE: Yes.
MR. BUTING: Likely, or the passenger door on the front?
SHERRY CULHANE: Yes.
MR. BUTING: From either one, but more likely the driver's door, you could reach the location where all of the stains were found in that front seat area?
SHERRY CULHANE: Except for the rear passenger door.
MR. BUTING: I'm getting to that. Okay? The first five that you found were all in that front compartment?
SHERRY CULHANE: Yes.
MR. BUTING: Front seat compartment?
SHERRY CULHANE: Yes.
MR. BUTING: Reachable by opening one door, right?
SHERRY CULHANE: Yes.
MR. BUTING: And, then, the only other stain that you found there was in the rear passenger door that could also be accessed simply by opening that one door?
SHERRY CULHANE: Yes.
MR. BUTING: So if somebody was to plant Mr. Avery's blood in that vehicle, before you got it on November -- in November, all of those stains you found could have been done by simply opening two doors?
SHERRY CULHANE: Yes.
MR. BUTING: Now, many months later, April I believe it was, you got a swab that was told to you was a hood latch swab?
SHERRY CULHANE: Correct.
MR. BUTING: That was not tested, or did not come from your test in November?
SHERRY CULHANE: Right.
MR. BUTING: And you weren't present when it was taken, by whomever, sometime before it arrived at your lab?
SHERRY CULHANE: No, I was not.
MR. BUTING: And you didn't do a presumptive test for blood, right?
SHERRY CULHANE: Correct.
MR. BUTING: You didn't see any blood particularly visible on the swab, right?
SHERRY CULHANE: Right.
MR. BUTING: But it was discolored?
SHERRY CULHANE: Yes.
MR. BUTING: Dirty, might possibly have had some residue of blood mixed in with the dirt and grime and whatever else was on the swab, right?
SHERRY CULHANE: It's possible, but there was no visual indication.
MR. BUTING: And you often -- well, not often, but you do sometimes find blood without visibly seeing it, right?
SHERRY CULHANE: Yes.
MR. BUTING: And your presumptive tests will usually indicate that?
SHERRY CULHANE: Correct.
MR. BUTING: But you didn't actually do one here, on this hood swab, right?
SHERRY CULHANE: Correct.
MR. BUTING: So you can't rule out the source of that DNA being a blood drop or a blood smudge of some sort, can you?
SHERRY CULHANE: No. I can --
MR. BUTING: That's fine.
SHERRY CULHANE: I can say that it wasn't a visible --
MR. BUTING: Sure. But you can't rule out that blood may have been the source?
SHERRY CULHANE: A very trace amount, yes.
MR. BUTING: Because this was a low amount, you say, right?
SHERRY CULHANE: Well, the entire swab was a low amount of DNA and that's why I didn't test it for presumptive, because I didn't want to waste any of the sample on a presumptive test.
MR. BUTING: Okay. We'll get to that in just a moment here. You also testified very, very briefly, I think, about Item B, which is Mr. Avery's own Pontiac Grand Am --
SHERRY CULHANE: Yes.
MR. BUTING: -- right?
SHERRY CULHANE: Yeah.
MR. BUTING: And you did test a number of stains or swabs that came to you, or did you actually get them yourself?
SHERRY CULHANE: I collected them.
MR. BUTING: You collected them, okay. And overall you found Mr. Avery's DNA on those swabs, right?
SHERRY CULHANE: Yes.
MR. BUTING: Not at all unusual to find one's own DNA on one's own possessions?
SHERRY CULHANE: Correct.
MR. BUTING: You didn't find Teresa Halbach's DNA on any of those items, or anywhere in Item B, the Pontiac Grand AM, did you?
MR. BUTING: And you certainly were looking for that if that was -- right, that was part of your test, part of your examination?
SHERRY CULHANE: Well, I just processed the blood samples and they were what they were.
MR. BUTING: And they were not Teresa's?
SHERRY CULHANE: Correct.
MR. BUTING: Okay. Let's turn to the key. Would this be something that you would consider that had trace levels of DNA?
SHERRY CULHANE: I guess it depends on how you define trace.
MR. BUTING: Let's say a relatively low amount of DNA in this particular instance?
SHERRY CULHANE: Yes.
MR. BUTING: If you could look at your notes maybe, refresh your recollection. I'm going to ask you in a moment about that. If you can give me some estimate, from your records, about just what the volume or level of DNA you found on that key was? Okay?
SHERRY CULHANE: Yes.
MR. BUTING: Now, I believe you testified that there was no blood visible on this item either?
SHERRY CULHANE: Correct.
MR. BUTING: But, again, you didn't do a presumptive test?
SHERRY CULHANE: No, I did not.
MR. BUTING: What you did was, you took a swab, a Q-tip, moistened with this distilled water, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you rubbed it all the way around, both sides, top, bottom, whatever, of the black plastic part of the key?
SHERRY CULHANE: Correct.
MR. BUTING: And the swab, I think in this instance you said was not discolored?
SHERRY CULHANE: That's correct.
MR. BUTING: Now, when you tested this swab from the key, you used the entire amount. You used the entire swab, didn't you?
SHERRY CULHANE: Yes.
MR. BUTING: Normally, you will try and just cut a swab in half, use half, save half?
SHERRY CULHANE: Yes, if there's enough, yes.
MR. BUTING: But this particular test, just by looking at it, looking at the item you were dealing with, you thought you couldn't do that.
SHERRY CULHANE: Well, I felt that being what we refer to as a touched item, and there being no visible indication of a biological fluid like blood, that, yes, I would probably have a low amount to start with.
MR. BUTING: Okay. So when I call something trace, I'm talking about this small amount of DNA that may be transferred by something less than the usual bodily fluids of blood, or -- well, let's just stick with blood.
SHERRY CULHANE: Yes. I mean, it all depends on the stain. There are touched items that have lots and lots of DNA present. Some touched items don't have that much. It just depends on who touches them and what the item is. So to generalize all touched items with the term trace amounts, I'm not sure that's accurate.
MR. BUTING: All right. You said you keep up with the literature in your field, right?
SHERRY CULHANE: I try.
MR. BUTING: And I take it, then, that you have read a report, a study by Ray Wickenheiser?
SHERRY CULHANE: I don't remember the name, may I see it.
MR. BUTING: Sure. I'm not going to actually mark it, but take a moment and look at it and see if you maybe recognize this article, or the study it refers to.
SHERRY CULHANE: Yes, I believe I have read this.
MR. BUTING: Okay. And this -- basically, this is an article published in 2002, says at the bottom, right?
SHERRY CULHANE: Yes.
MR. BUTING: And the title is, Trace DNA: A Review Discussion of Theory and Application of the Transfer of Trace Quantities of DNA Through Skin Contact, right?
SHERRY CULHANE: Yes.
MR. BUTING: This article, among other things, talks about some of the different theories about how one actually transfers DNA by touch or by skin.
SHERRY CULHANE: Yes.
MR. BUTING: And there's different theories. Some people think that it's really just a transfer of some bodily fluids, somebody who rubs their eyes, like this, maybe gets some tears on it, then picks something up, right?
SHERRY CULHANE: Well, anytime you touch your body and you have cells on your hands, then that would be a way to transfer it.
MR. BUTING: Sure. Or if you touch your mouth, you know, something like that, you have got your fingers to your mouth and then you touch something, you may be transferring DA (sic) through little bits of saliva, right?
SHERRY CULHANE: Well, again, you are talking about skin. I mean, even just your hands are going to slough off skin, so you don't have to really touch your face, you just touch something with your hands you will leave --
MR. BUTING: But you are aware, though, that there is kind of a dispute in the field of people that are studying this, as to whether or not the cells, just the epithelial cells that you are shedding from your fingers alone is enough to produce a DNA result or profile, or whether, in fact, what really is happening is you are transferring some bodily fluid to your fingers and then touching it and transferring it that way?
SHERRY CULHANE: I understand there's probably different opinions, but the bottom line is, if you touch something with your hand, or any part of your body, and you leave cells, it has the potential for our DNA profile.
MR. BUTING: Okay. And I don't know if you had a chance to look at your notes yet?
SHERRY CULHANE: Yes.
MR. BUTING: Can you tell me approximately -- if I told you that the amount recovered in that swab of the key was somewhere between -- somewhere around 20 nanograms of DNA, would that be a ballpark?
MR. BUTING: What do you come up with?
SHERRY CULHANE: Well, actually, in the whole sample, you may be right. My quantitation is .17 for one microliter.
MR. BUTING: Sure. But you have to add volume to it and --
SHERRY CULHANE: And the total amount of the extract was probably around 30 to 35 microliters.
MR. BUTING: Okay. So a little bit more than what I said.
SHERRY CULHANE: Yes.
MR. BUTING: You are familiar with tests of liquid blood would have DNA in the amount of over 20,000 nanograms, something like that?
SHERRY CULHANE: I don't recall exact numbers, no.
MR. BUTING: And how about buccal or buccal swabs, are you aware that they have, generally, anywhere from couple thousand maybe, 2,000, 3,000?
SHERRY CULHANE: Again, I don't recall exact numbers.
MR. BUTING: Let me show you another study, see if you recognize that. It's a study by Henry Lee (phonetic), Karl Ladd (phonetic), does that look at all familiar?
SHERRY CULHANE: No, I have never read this.
MR. BUTING: Okay. Have you read anything that tells you, or that's made some kind of determination of what the volume of -- or in terms of nanograms, what the amount of DNA one would typically find in a buccal swab.
SHERRY CULHANE: Sure. I just don't recall the exact number.
MR. BUTING: Okay.
SHERRY CULHANE: But it's obviously much more DNA in a buccal swab or a blood sample. Those are rich sources of DNA, so there's going to be a lot of DNA there.
MR. BUTING: Sure. And if one was to take a buccal swab and rub it on the key in this case, it might transfer 30, 35 nanograms of DNA?
SHERRY CULHANE: I have no idea.
MR. BUTING: Well, would that be an unreasonable amount, or reasonable?
SHERRY CULHANE: I really -- There's no way for me to comment on that. And there's no -- you may transfer a lot of DNA, you may not transfer very much at all.
MR. BUTING: Okay.
SHERRY CULHANE: There's really no way to answer that.
MR. BUTING: Would it be fair to say that the DNA volume or amount that you found on that key was not very much?
SHERRY CULHANE: No, it was a low level, yes. That's correct.
MR. BUTING: Low level. If one was to rub a toothbrush up against a key, that might also transfer some low level amount of DNA to the key, right?
SHERRY CULHANE: That would be possible, however, in my experience toothbrushes are not a real good source of DNA. It's very difficult to get a profile from a toothbrush.
MR. BUTING: That's when you test the toothbrush itself. But in terms of transferring just 30 to 35 nanograms of DNA, that could be done by rubbing a toothbrush on it, potentially?
SHERRY CULHANE: Like I said, it's possible but.
MR. BUTING: And it's also possible to get that amount by rubbing a buccal swab against the key as well, right?
SHERRY CULHANE: Yes.
MR. BUTING: There are many ways, many personal items that someone might rub against a key that might also shed and deposit a low amount of DNA like such as you found on this key?
SHERRY CULHANE: Yes, it's possible.
MR. BUTING: Okay. And from looking at this key, and your swab, and the evidence you found, you cannot tell whether the DNA that was found on that key was planted there by somebody or not, can you?
MR. BUTING: And, indeed, if somebody did plant the DNA on that key that you determined -- that you found in your tests, it would look much like what you found?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, you found no mixture of DNA on that key, right?
SHERRY CULHANE: Right.
MR. BUTING: You did not find any DNA of Teresa Halbach on that key, did you?
SHERRY CULHANE: That's correct.
MR. BUTING: A car key that presumably she handled and used daily, right?
SHERRY CULHANE: Correct.
MR. BUTING: And you did swab all the way around the key?
SHERRY CULHANE: Yes.
MR. BUTING: Now, there are some studies in the Wickenheiser report, for instance, that talk about how the last person who touches an item may leave the major portion of DNA that's left on there?
SHERRY CULHANE: Yes.
MR. BUTING: But most often when that happens, there's still a mixture and there's a minor contributor as well, right?
SHERRY CULHANE: No, I -- I would disagree with that. In some cases, yes. It's very difficult. There's no way to really predict that. If you have someone who's a good shedder and sheds a lot of DNA, when they touch something, a lot of studies show that that is going to be --the last person is going to be the DNA you pick up. If you don't shed a lot of DNA, then you may not find any at all.
MR. BUTING: What you found on this key was not a lot of DNA, right?
SHERRY CULHANE: Correct.
MR. BUTING: Turn to page 448 of that article, I'm going to ask you to agree or disagree with this.
SHERRY CULHANE: Yes.
MR. BUTING: Paragraph begins, as the sensitivity, do you see that?
SHERRY CULHANE: Yes.
MR. BUTING: About half way down?
SHERRY CULHANE: Mm-hmm.
MR. BUTING: Do you agree or disagree with this statement: Although case experience has found that the handled object bears the profile of the most recent handler, many more mixed profiles will be recovered if commonly handled objects are examined, doorknobs, handles, light switches, ignition switches, and doorbells have all yielded DNA profiles. And then there's a table that's referred to.
SHERRY CULHANE: Yes.
MR. BUTING: You agree with that?
SHERRY CULHANE: In many of the cases, yes, but not all the time.
MR. BUTING: Okay. Let's go to the bullet for a minute, just to clear up a couple of things. The bullet that you, tested you didn't get it until April, or March actually. right?
SHERRY CULHANE: Yes, that's correct.
MR. BUTING: And to the eye, you didn't see any blood visible?
SHERRY CULHANE: That's correct.
MR. BUTING: But you didn't do a presumptive test?
SHERRY CULHANE: Right.
MR. BUTING: And, in fact, did you do a swab at all?
MR. BUTING: This is one where you put it into a buffer and sort of dissolved the amount, right?
SHERRY CULHANE: Yes, I washed it.
MR. BUTING: So you can't really say whether the DNA on that bullet came from blood or some other source, can you?
SHERRY CULHANE: All that I can say is it was nucleated cells.
MR. BUTING: Which could mean blood or any other sources?
SHERRY CULHANE: Right.
MR. BUTING: Let's talk about some specific results that you did get and we haven't heard. Out of all the tests that you did, 180 items that you looked at, came into your lab, right?
SHERRY CULHANE: Yes.
MR. BUTING: No DNA of Teresa Halbach's was ever found on any item that was indicated it came from Mr. Avery's house, correct?
SHERRY CULHANE: That's correct.
MR. BUTING: No DNA of Teresa Halbach was ever found on any swabs of Mr. Avery's car?
SHERRY CULHANE: Correct.
MR. BUTING: No DNA of Teresa Halbach was ever found on any item, or on the surface inside his Ford F350 pickup?
SHERRY CULHANE: I don't believe I examined the pickup.
MR. BUTING: Okay. And no DNA was found of Teresa Halbach's on any item, any item in that garage, detached garage next to Steven Avery, with the exception of that one bullet, FL?
SHERRY CULHANE: Correct.
MR. BUTING: In a test that you admit showed contamination, correct?
SHERRY CULHANE: In the control, not the evidence.
MR. BUTING: In the test, correct?
SHERRY CULHANE: As I said, in the control, not the evidence.
MR. BUTING: All right. We'll pursue that later, but it will probably have to be after lunch. But let's go through some of the items. You never found any of Teresa Halbach's DNA on any kind of mattress or bedding, did you?
SHERRY CULHANE: I don't believe I examined any mattress or bedding.
MR. BUTING: Okay. So none of that was even sent to you, right?
SHERRY CULHANE: Correct.
MR. BUTING: You never found any DNA of Teresa Halbach's on any carpet in his house, did you?
MR. BUTING: There were some stains that were sent to you that I want to make clear the jury isn't confused about, though. There was a stain that was found that appeared to be a blood drop on the bathroom floor, right?
SHERRY CULHANE: There were several items on the bathroom floor. I don't know which one you are referring to.
MR. BUTING: Let's put them all together. All the bathroom items, the floor, the vanity, the sink, whatever, right?
SHERRY CULHANE: Mm-hmm.
MR. BUTING: You tested all of those?
SHERRY CULHANE: Correct.
MR. BUTING: None of them had Teresa Halbach's blood on them, did they?
MR. BUTING: You also tested, there were some drops that were found on a molding of a door near the bathroom or bedroom, right?
SHERRY CULHANE: Yes.
MR. BUTING: No DNA of Teresa Halbach, right?
SHERRY CULHANE: Correct.
MR. BUTING: You tested the headboard of a bed, right?
SHERRY CULHANE: Yes.
MR. BUTING: You tested the footboard of a bed?
SHERRY CULHANE: Just the headboard, I believe.
MR. BUTING: Do you have your reports with you?
SHERRY CULHANE: Yes, I do.
MR. BUTING: All right. I stand corrected, looks like you tested several items, several areas of the headboard, right?
SHERRY CULHANE: Yes.
MR. BUTING: The legs, the spindle things, right?
SHERRY CULHANE: Yes.
MR. BUTING: No DNA of Teresa Halbach?
SHERRY CULHANE: Correct.
MR. BUTING: You tested stains that were recovered from the nightstand in Mr. Avery's bedroom, right?
SHERRY CULHANE: I don't recall if I looked at stains from a nightstand.
MR. BUTING: May 8th report, second page, Item HX and Z.
SHERRY CULHANE: That's correct, you're right.
MR. BUTING: No DNA from Teresa Halbach?
SHERRY CULHANE: Correct.
MR. BUTING: You also tested outlet covers, and light switches, from Mr. Avery's house?
SHERRY CULHANE: Yes.
MR. BUTING: No DNA from Teresa Halbach?
SHERRY CULHANE: That's correct.
MR. BUTING: And you tested the handcuffs and leg irons?
SHERRY CULHANE: That's correct.
MR. BUTING: None of Teresa Halbach's DNA found on either of those items?
SHERRY CULHANE: That's correct.
MR. BUTING: Which we decided -- which you said earlier, clearly had hot been cleaned off with bleach or something because they had a mixture of other people's DNA on it?
SHERRY CULHANE: That's correct.
MR. BUTING: Then you examined many knives that were sent to you, right?
SHERRY CULHANE: Yes.
MR. BUTING: I see at least seven just in the May 8th report, right?
SHERRY CULHANE: Yes.
MR. BUTING: No DNA of Teresa Halbach's?
SHERRY CULHANE: Correct.
MR. BUTING: In the garage -- Actually, Judge, I don't know what time you want to break for lunch. I may have yet another 10 or 15 minutes on this part of it before I move so.
THE COURT: All right. I didn't know how long this part was going to go. If that's the case, we'll take our lunch break at this time. Members of the jury, do not discuss the case or any of this morning's testimony during your lunch break.
(Jury not present.)
THE COURT: You may be seated. Counsel, let's report back about 1:00 then.
MR. BUTING: Okay. Thank you.
(Noon recess taken.)
(Jury present.)
THE COURT: Mr. Buting, you may resume your cross-examination.
MR. BUTING: Thank you, your Honor.
CROSS-EXAMINATION CONTD. BY ATTORNEY BUTING:
MR. BUTING: All right. Ms Culhane, you were talking about all of the items in the house that you looked at. And would it be fair to say that you were not able to -- as Mr. Fassbender requested -- put her in his house?
SHERRY CULHANE: That's correct.
MR. BUTING: So then you looked at the garage as well, not sequentially, but at some point you were looking at the garage?
SHERRY CULHANE: Yes.
MR. BUTING: And they sent you a number of stains. I'm going to show you a couple of exhibits that were introduced earlier, take a look at them and then I will put them up on the screen.
SHERRY CULHANE: Okay.
MR. BUTING: Okay. I'm showing you Exhibit 247 first, a number of evidence markers there. We had testimony that -- where all those one, two, three, up to eight, I believe, swabs were taken? Okay?
SHERRY CULHANE: Yes.
MR. BUTING: And you tested those swabs, right?
SHERRY CULHANE: I assume so.
MR. BUTING: Well, if you need to refer to your notes, you did find some DNA on garage floor stains in this case, right?
SHERRY CULHANE: Yes, I was submitted a number of swabs and I gave them my item designations when they came in. I was not -- I didn't actually collect them.
MR. BUTING: Okay. I understand. But you did indicate, looking now at your March 31st report -- if you need to refer to it that's fine -- a number of items, question stain, reportedly recovered from the garage floor, right?
SHERRY CULHANE: Yes.
MR. BUTING: You have got Item G through P described that way?
SHERRY CULHANE: Yes.
MR. BUTING: And they have different tag numbers associated with them. Those are the tag numbers from the -- presumably the law enforcement people who submitted them?
SHERRY CULHANE: Correct.
MR. BUTING: And when you tested those, you found out that six of them had DNA -- had Mr. Avery's own DNA?
SHERRY CULHANE: Yes, that's correct.
MR. BUTING: Now, if you are getting a DNA reading off of swabs, that must mean -- or correct me if I'm wrong -- that no one had tried to clean that area with bleach before the swabs were taken, right?
SHERRY CULHANE: I really -- I don't know.
MR. BUTING: Okay. Let me ask it this way, that was poorly phrased. Looking at this exhibit on the screen right now, which is a photograph of the garage, if somebody had cleaned that garage floor with bleach before the police came, you would not expect to find any DNA would you?
SHERRY CULHANE: If it was cleaned thoroughly enough and the bleach destroyed all the DNA, no, I wouldn't.
MR. BUTING: Okay. But in this case, you did find DNA. You found Mr. Avery's own DNA?
SHERRY CULHANE: That's correct.
MR. BUTING: And, again, it's not unusual, nothing sinister about finding one's own DNA in one's own property, is it?
MR. BUTING: And then later in the case, return to your December report, and, actually, you can see part of it in this exhibit up there, you see that crack that runs along the left side?
SHERRY CULHANE: Yes.
MR. BUTING: I will put on Exhibit 237 right now, to show it a little better. See that crack that sort of runs north/south in this garage?
SHERRY CULHANE: Yes.
MR. BUTING: It's your understanding that law enforcement actually took a jackhammer into this garage and tore up concrete chunks, right?
SHERRY CULHANE: That was my understanding.
MR. BUTING: And they did that because they thought, well, if the victim had been killed here, perhaps her blood would have soaked into those cracks, right?
SHERRY CULHANE: I assume so.
MR. BUTING: And so this crack was divided into a bunch of different concrete chunks, that were later sent to you?
SHERRY CULHANE: The swabs from the chunks were, yes.
MR. BUTING: Okay. I apologize, the swabs from the chunks. And in your December report, there was actually -- my gosh, almost three full pages of swabs, right?
SHERRY CULHANE: Correct.
MR. BUTING: Did you find Teresa Halbach's DNA on any of those swabs?
SHERRY CULHANE: No, I did not.
MR. BUTING: You did find Mr. Avery's DNA on one of them though, right?
SHERRY CULHANE: Correct.
MR. BUTING: Now, you also looked, or asked to look, we saw that message earlier, at the -- at .22 rifle swabs that were taken from it, right?
SHERRY CULHANE: Yes.
MR. BUTING: And the purpose there was not to see if you would find Teresa Halbach's DNA, but to see if you would find Mr. Avery's DNA, right?
SHERRY CULHANE: Was that item DD?
MR. BUTING: Yes.
SHERRY CULHANE: I believe I was requested to look for possible blood on the barrel part and DNA from the trigger area.
MR. BUTING: And you found neither, correct?
SHERRY CULHANE: That's correct.
MR. BUTING: You did not find Mr. Avery's DNA on that weapon anywhere, did you?
SHERRY CULHANE: On the trigger guard is the only place I swabbed, but, no, I didn't.
MR. BUTING: And you did not find Teresa Halbach's DNA anywhere on the barrel either?
SHERRY CULHANE: Correct.
MR. BUTING: Are you familiar with close -- close, almost contact-type shootings?
SHERRY CULHANE: I don't know what you mean by that.
MR. BUTING: Are you familiar with the term blow back?
SHERRY CULHANE: Yes.
MR. BUTING: You know that if someone shoots another human being with a gun, that's very close to them, there may be blow back spatter of blood onto that weapon?
SHERRY CULHANE: I assume that's possible.
MR. BUTING: Well, that's what you were looking for?
SHERRY CULHANE: I was simply looking for blood stains, yes.
MR. BUTING: On the barrel?
SHERRY CULHANE: Correct.
MR. BUTING: And you found none?
SHERRY CULHANE: Correct.
MR. BUTING: You also were asked to look at license plates that were recovered?
SHERRY CULHANE: Yes.
MR. BUTING: Two of them, right?
SHERRY CULHANE: Yes.
MR. BUTING: Two of them that, at least your understanding was, were the license plates originally on that RAV 4?
SHERRY CULHANE: That was my understanding, yes.
MR. BUTING: And you didn't find Mr. Avery's DNA on that, did you?
SHERRY CULHANE: No, I did not.
MR. BUTING: By the way, in all of this evidence that you have tested, all of it, some of it we heard you found Mr. Avery's DNA, things in his own garage or his own house, right?
SHERRY CULHANE: Yes.
MR. BUTING: Did you ever find any DNA of a gentleman named Brendan Dassey, anywhere, in all of your tests?
SHERRY CULHANE: No, I did not.
MR. BUTING: Not one shred, right?
SHERRY CULHANE: No, I did not find his DNA.
MR. BUTING: And you had his profile?
SHERRY CULHANE: Yes, I did.
MR. BUTING: All right. I want to talk about contamination. All right?
SHERRY CULHANE: Yes, sir.
MR. BUTING: You are aware it can happen?
SHERRY CULHANE: Yes.
MR. BUTING: In a lab. It's happened in your lab, you know that?
SHERRY CULHANE: Yes.
MR. BUTING: And we talked about contamination that may occur before it ever gets to your lab, intentional or otherwise, right?
SHERRY CULHANE: Right.
MR. BUTING: But you are involved in quality control at your own lab?
SHERRY CULHANE: That's correct.
MR. BUTING: Are you like the head honcho there, in charge of quality control?
SHERRY CULHANE: No, I just monitor the quality control in our unit.
MR. BUTING: The DNA unit?
SHERRY CULHANE: Correct.
MR. BUTING: So, you are responsible for making sure that the quality that comes out of your DNA unit is good?
SHERRY CULHANE: Correct.
MR. BUTING: And because DNA is very small, and relatively easily contaminated, you take steps to try and prevent that, right?
SHERRY CULHANE: Yes.
MR. BUTING: You mentioned a couple of them, but, for instance, you have seen instances where, during a test, material from one case may end up getting contaminated into another case?
SHERRY CULHANE: Yes, that's happened.
MR. BUTING: Okay. You try to minimize that. That last one, idea or example I gave you, would be called cross-contamination, right?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. So the analysts wear, you mentioned, gloves?
SHERRY CULHANE: Yes.
MR. BUTING: Um, lab coats?
SHERRY CULHANE: Yes.
MR. BUTING: Glasses?
SHERRY CULHANE: Yes.
MR. BUTING: And you said you bleach down the instruments in the test areas before -- in between tests?
SHERRY CULHANE: That's correct.
MR. BUTING: At least you try to. And you try and -- You mentioned this amplification room, you try and stay out of that, or you know, or when you are working in there, stay in there, and do your test, and be done, right?
SHERRY CULHANE: Correct.
MR. BUTING: And despite all this, all these precautions, the Wisconsin Crime Lab still experiences the phenomena of contamination, does it not?
SHERRY CULHANE: Correct.
MR. BUTING: Now, there's some things -- other things you could do. For instance, you could wear masks, like surgeons do, right?
SHERRY CULHANE: Correct.
MR. BUTING: You don't?
MR. BUTING: You could use disposable lab coats that you throw out once you move from one room to the next, right?
SHERRY CULHANE: We do have different lab coats that we use from one room to the next. We have a different lab coat for the amplification room than our work area.
MR. BUTING: Okay. All right. But you don't change lab coats when you work from one case to the next?
SHERRY CULHANE: No, we don't.
MR. BUTING: And you don't use -- are you familiar with something called biological containment hood?
SHERRY CULHANE: Yes.
MR. BUTING: They're like a -- almost like a range that you -- that someone would see in their home, with a hood bent over it?
SHERRY CULHANE: Yes.
MR. BUTING: And it's got a work space inside of it?
SHERRY CULHANE: Yes.
MR. BUTING: And it has filtered air circulating through it?
SHERRY CULHANE: Yes.
MR. BUTING: And it's designed to prevent outside contaminants from coming in?
SHERRY CULHANE: Yes, and we have two of those hoods that we use to set up our amplification. After our samples were processed, we set those up in a hood very much like that.
MR. BUTING: Okay. But when you are working on extractions and that sort of thing you don't --
SHERRY CULHANE: Correct.
MR. BUTING: -- use those kinds of hoods, right?
SHERRY CULHANE: Correct.
MR. BUTING: It's just out on your table or your bench as you are working, right?
SHERRY CULHANE: Right.
MR. BUTING: And right next to you in this T, at the other end, may be one more analyst or two more analysts?
SHERRY CULHANE: One more analyst.
MR. BUTING: Okay. Now, since you know that there's a potential for contamination, you use what's called controls, to try and minimize that, or catch it if it happens, right?
SHERRY CULHANE: Right.
MR. BUTING: These are internal controls, right?
SHERRY CULHANE: Well, yes, they are controls that we set up with each -- with different phases of the examination.
MR. BUTING: Okay. And just want to take a moment to explain to the jury how this works. You actually have, when you run any kind of a DNA test, start to finish, you run what's called a positive control at the same time, goes through the whole sequence?
SHERRY CULHANE: No, sir. We have -- The positive control that you may be referring to is our amplification control. And that's only introduced in the amplification part of the process.
MR. BUTING: Okay. I stand corrected. But that positive control, basically, is a known DNA profile that you expect to get as it goes through the test, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you go through the test and you don't get that profile, you know something is wrong?
SHERRY CULHANE: Correct.
MR. BUTING: And then you also have what is called a negative control, which is supposed to go through and do what?
SHERRY CULHANE: Well, we have two samples that could be considered negative controls. We call the first one a manipulation control. And that's the one we set up with the extraction. And that is carried through the entire procedure. We have an additional negative control that is introduced in the amplification process. And that's carried through the last part of the procedure.
MR. BUTING: Okay. Well, let's talk about that one just for the moment, just to get rid of it. That negative control you introduced in the amplification process only?
SHERRY CULHANE: Yes.
MR. BUTING: And if it goes all the way through and comes up with something other than zero, you know something is wrong?
SHERRY CULHANE: Correct.
MR. BUTING: But back at the extraction part, you motioned with your hands, there's sort of like an item that's about the size of a brick maybe, that you put these samples in and run it through?
SHERRY CULHANE: Well, we set our samples up in a test tube rack, and they are different sizes.
MR. BUTING: Okay. And so they are altogether sitting in a rack, and go through some machine, is that it, when you extract them?
SHERRY CULHANE: No, these extractions are all done manually, by the analyst. And you set them up, your evidence samples, one in each tube, and then at the end of the process you add a tube that is a negative control with all of the reagents that you added into your sample.
MR. BUTING: Okay. And that negative control you are talking about is what you call manipulation control?
SHERRY CULHANE: Yes.
MR. BUTING: But what I'm getting at is, when you run this whole block of samples through, whatever machine it is you do, there's more than one case in it, right? Often?
SHERRY CULHANE: In the extraction procedure, no. When we amplify -- or I mean, I'm sorry, when we quantitate, there can be more cases batched together. And then when we amplify, we amplify them singly in a set, and then it's put on the instrument in batches.
MR. BUTING: Okay. So the first thing, this extraction thing that you do by -- manually, you then get a reading and it tells you whether there's any DNA that's worth even pursuing, right?
SHERRY CULHANE: That's part of the quantitation, yes.
MR. BUTING: Okay. Well, if there is enough, then you quantify it, do that test, and then go into amplification?
SHERRY CULHANE: The quantitation part tells us if there is enough. If there is enough, then we continue. If not, we stop there.
MR. BUTING: Okay. So this manipulation control that you are talking about is supposed to be zero, right?
SHERRY CULHANE: Yes.
MR. BUTING: It's supposed to be -- When you go through the test, it is supposed to show no human DNA whatsoever, correct?
SHERRY CULHANE: Correct.
MR. BUTING: And the reason you call it a control is because if you do the test, and at the end you find out, hey, there's something in here, then that's a clue that there is contamination, right?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, contamination of evidence samples is harder to detect than these contaminations of the controls, right?
SHERRY CULHANE: Not necessarily, depends.
MR. BUTING: Well, with the control, if it comes back anything other than zero, you know there's something contaminating it, right?
SHERRY CULHANE: Right.
MR. BUTING: With an evidence sample, if it comes back with DNA, if that DNA had been contaminated, you wouldn't necessarily know that?
SHERRY CULHANE: Correct. If it had been contaminated with the same type of DNA, that's correct. However, if it's been contaminated with another type, or the analyst, or another source of the DNA, it would show up as a mixture of DNA and we would be able to separate that out.
MR. BUTING: Well, it would show up as a mixture if the original piece of evidence had any DNA that was testable -- detectable, right?
SHERRY CULHANE: Yes.
MR. BUTING: A lot of these samples you will test and you don't find any DNA on them, right?
SHERRY CULHANE: Right. And at that point, we wouldn't go any further.
MR. BUTING: Sure. But if that sample that has really no DNA on it, gets contaminated in this process, with some other DNA, from it's own case or another case, you wouldn't necessarily know it when you go through this test, would you?
MR. BUTING: Meaning correct?
SHERRY CULHANE: Yeah, that's correct.
MR. BUTING: Because at the end, you would get a profile, on the piece of evidence, and you would assume that that profile must be from the suspect, or must somehow be related to the case, right?
SHERRY CULHANE: Correct.
MR. BUTING: You wouldn't know that it had been contaminated before it even went through?
SHERRY CULHANE: Correct.
MR. BUTING: Okay. Now, you keep a log of these kinds of contamination incidents, correct?
SHERRY CULHANE: Yes.
MR. BUTING: I'm going to mark this. I have already shown counsel.
(Exhibit No. 346 marked for identification.)
MR. BUTING: We'll call this Wisconsin Crime Lab's Contamination Log. I think you changed the names a couple times, but that's Exhibit 346. Can you identify that.
SHERRY CULHANE: Yes, these are copies from the logs that we keep in the lab.
MR. BUTING: Okay. And the first few pages are in a different format. They are like a full page, each deals with one incident, correct?
SHERRY CULHANE: Yes.
MR. BUTING: But as you get back a little bit farther, really, just before August of this past year, August '06, it's more of a log with numerous incidents on each page --
SHERRY CULHANE: Yes.
MR. BUTING: -- right?
SHERRY CULHANE: Yes, we changed our forms.
MR. BUTING: Okay. You will need this with you so you can refer to it. Did you bring a copy of that with you, by the way, in your own file?
MR. BUTING: Okay. You don't normally keep that in your files when you come to court?
MR. BUTING: Now, what your policy at the lab is, whenever you run through these tests and you find a contamination such as a manipulation control contamination, you make a note of it in this log?
SHERRY CULHANE: Yes.
MR. BUTING: And you put the date, the case number, the type of error detected, the analyst, and then there's some corrective action that's taken?
SHERRY CULHANE: Yes.
MR. BUTING: But, again, that, of course, is only in those manipulation or those control cases where you can see clearly that there's contamination because it's something other than zero?
SHERRY CULHANE: Correct.
MR. BUTING: Now, despite the best efforts of the analysts and their supervisors, sometimes no explanation can be found for the contamination; is that fair?
SHERRY CULHANE: Yes.
MR. BUTING: Sometimes it's rather obvious, like in your case in this instance, that your DNA is found in a control and then it's assumed that somehow you contaminated it yourself, the analyst, right?
SHERRY CULHANE: Right.
MR. BUTING: But other times it's baffling, somehow or another, something was contaminated and no one can figure out how or why?
SHERRY CULHANE: Correct.
MR. BUTING: I want you to take a minute and look at this exhibit that's in front of you. It's a 24 month period, basically, from November of '04 -- actually, December of '04 to December of '06. Could you count the number of errors -- You said earlier that you believe there were 89 errors since 2001.
SHERRY CULHANE: Right.
MR. BUTING: Do you remember that?
SHERRY CULHANE: Yes.
MR. BUTING: Would you count how many contamination incidents are recorded in that 24 month period from 2004 to 2006.
SHERRY CULHANE: Fifty.
MR. BUTING: All right. Take a minute and count how many you have, how many errors, contamination errors, you report, yourself, in that 2 month period -- 24 month period? I believe I counted 44 errors, but you must have found some more.
SHERRY CULHANE: Seven.
MR. BUTING: Actually, if you look at the third to the last page, begins, it has three there, starting March of '04. That's all right, never mind. So you count 7, 7 out of 50.
SHERRY CULHANE: Yes.
MR. BUTING: I counted 8, but maybe I miscounted. You said there's about 10 analysts?
SHERRY CULHANE: Anywhere from 10 to 12.
MR. BUTING: Okay. So, if there's 50 errors, the average, if spread evenly, should be five errors a person, right?
SHERRY CULHANE: That depends on how many cases each analyst works.
MR. BUTING: That's true. You, though, have 7 out of 50, which is more than the average, if you divide it evenly, correct?
SHERRY CULHANE: But not all those analysts work the same number of cases.
MR. BUTING: That's true. However, some of them are full-time --
SHERRY CULHANE: They are all full-time.
MR. BUTING: -- doing nothing but DNA. All of them.
SHERRY CULHANE: They are all full-time.
MR. BUTING: They are all full-time, and you are not. You are 70 percent; 70 percent of your time is doing DNA testing, that's what you told us, right?
SHERRY CULHANE: That's correct.
MR. BUTING: So we have all these other analysts who are working full-time, more cases than you, and yet you have a higher error rate than anyone.
SHERRY CULHANE: No, actually, I believe if you look at the numbers, I'm one of the higher producing analysts as far as number of cases.
MR. BUTING: Well, I don't see those numbers, but I do see that you are the highest producing contamination person in this log; isn't that right?
THE COURT: Sustained. I will ask that you rephrase the question.
MR. BUTING: (By Attorney Buting)~ Isn't it true that for this two month -- two year period, you have one of the highest contamination records of anybody at the Wisconsin Crime Lab in Madison?
SHERRY CULHANE: I don't know, I haven't counted up all the other instances of other people. So I really don't know how many each analyst has.
MR. BUTING: Well, take a moment and look if you like.
SHERRY CULHANE: Do you want me to count up for each analyst?
MR. BUTING: I want you to see if there's anybody who has more errors in that 20 more -- 24 month period than you?
MR. GAHN: Your Honor, I'm going to object at this point to the relevancy of this, number one. But, also, I think, foundationally, what the other analysts -- I don't know how this witness can testify to the causes or why there was contamination in other analyst's cases.
THE COURT: I think that's a matter for redirect. I'm going to allow the question.
MR. BUTING: (By Attorney Buting)~ Would you agree with me that you have more errors in that 20 month -- 24 month period than anybody?
SHERRY CULHANE: If you counted them up and your numbers are correct, then I agree with you.
MR. BUTING: Now, let's look at -- Why don't you look at just the months of September and August of 2006, count how many errors there are total and how many of them are yours?
SHERRY CULHANE: September and August?
MR. BUTING: Yes.
SHERRY CULHANE: 2006.
MR. BUTING: These are all the big sheets, right, full page ones?
SHERRY CULHANE: Yes, there's only one.
MR. BUTING: There's eight errors in September and August total for the lab, right?
SHERRY CULHANE: Oh, I thought you said for me.
MR. BUTING: Well, let's just talk about first for the lab?
SHERRY CULHANE: Oh, for the lab. Five.
MR. BUTING: Go to the next page that has a log of several, August 1st, August 3rd --
SHERRY CULHANE: I'm sorry, you're at five, okay.
MR. BUTING: August 1st, August 3rd, August 28th, 29th, September 6th, September 14th. And on the second page, another on August 3rd and another on August 29th.
SHERRY CULHANE: Seven.
MR. BUTING: Okay. You come up with seven, two of which are yours. Look at September 6th.
SHERRY CULHANE: Yes.
MR. BUTING: And look at August 1st?
SHERRY CULHANE: I don't have that.
MR. BUTING: I'm sorry. You're right, there's a page missing from this exhibit. I'll correct that, but here's a photocopy of apparently a page I didn't have in this exhibit, shows an August 1st entry.
SHERRY CULHANE: Okay.
MR. BUTING: With an error from you, right?
SHERRY CULHANE: Yes.
MR. BUTING: So in that two month period, two of the seven errors were made by you?
SHERRY CULHANE: Yes.
MR. BUTING: And in October and November of 2006, I count eight of these sheets, eight errors?
SHERRY CULHANE: Total.
MR. BUTING: Total, right? So in the lab, in the four month period of October, November, September, and August, you have got 15 errors already, just in that one little period of time, right?
SHERRY CULHANE: Yes.
MR. BUTING: Would you agree with me that the contamination error rate has been going up in the Crime Lab over the last few years?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, look, just for a moment, at some of these contaminations so we can talk about what kind of contaminations there are. Would you turn to one that's entered on October 18th of 2006. Do you see the October 18th?
SHERRY CULHANE: Yes.
MR. BUTING: Case No. W06-1209?
SHERRY CULHANE: Yes.
MR. BUTING: Okay. Now, this is not a mistake or an error contamination by you, but you did sign off at the bottom of it as the DNA Technical Unit leader, right?
SHERRY CULHANE: Correct.
MR. BUTING: So you are familiar with what happens here when your analysts make -- do a test; they find contamination; they have to do one of these reports; you review it and the supervisor reviews it, right?
SHERRY CULHANE: Correct.
MR. BUTING: And this is an instance of cross-contamination between two completely different cases, is it not?
SHERRY CULHANE: Yes.
MR. BUTING: And the corrective measure for this particular analyst is that she or he, I don't know who it is, is going to try not to extract high level DNA samples near in space in time to low level DNA samples?
SHERRY CULHANE: Correct.
MR. BUTING: So that one was apparently explained. Now, if you look at the very next page, different case W05-1876?
SHERRY CULHANE: Yes.
MR. BUTING: Do you see that one?
SHERRY CULHANE: Yes.
MR. BUTING: Description of the contamination here is believed to have been a problem with labeling. Hold on, I'm sorry, it's the next page, W05-140?
SHERRY CULHANE: Yes.
MR. BUTING: This is a contamination where it was concluded that it's possible the samples were actually switched or mislabeled during the test process?
SHERRY CULHANE: Yes, it's possible.
MR. BUTING: And the corrective measure is specifically to limit distractions and to limit cases working at one time in order to prevent errors, correct?
SHERRY CULHANE: Yes.
MR. BUTING: Distractions like you faced when you tested that bullet with trainees around you?
SHERRY CULHANE: No, I believe she was referring to distractions like phone calls and questions and.
MR. BUTING: Okay. There's also something called carryover, as another kind of contamination, right?
SHERRY CULHANE: Yes.
MR. BUTING: And that's referred to in the very next incident. And that's where it's possible for DNA from a prior test, to actually carryover into the one you are doing, through the instruments somehow, right?
SHERRY CULHANE: No. Are you talking about the one dated 10/8?
MR. BUTING: Well, yeah, but there's a number that talk about carryover. I'm just asking in general.
SHERRY CULHANE: Carryover in this instance would be to carryover in the same case, not case to case, into the control, from one sample to another into the control.
MR. BUTING: Okay. Let's turn to your error noted on September 6 of '06?
SHERRY CULHANE: Yes.
MR. BUTING: This is another one where you developed your profile from a swabbing of evidence, Item A?
SHERRY CULHANE: Yes.
MR. BUTING: This was evidence, not a control?
SHERRY CULHANE: That's correct.
MR. BUTING: You contaminated evidence in this instance, did you not?
SHERRY CULHANE: With my own DNA.
MR. BUTING: With your own DNA?
SHERRY CULHANE: Correct.
MR. BUTING: And you even entered it into CODIS, which is the big national data base?
SHERRY CULHANE: Right.
MR. BUTING: As a female DNA that somebody could hit on?
SHERRY CULHANE: Right. And because we have a system in the lab to catch this, we have profiles of everybody in the lab, my profile included. So this was resolved because it obviously hit on myself and it was removed.
MR. BUTING: But it wasn't even detected until you ran your own profile through CODIS, as if you were some suspect, right?
SHERRY CULHANE: It was detected when we ran it through the system, yes.
MR. BUTING: That's right. And so you had to then remove it from the whole CODIS system, otherwise you would look like you are some suspect?
SHERRY CULHANE: That's correct.
MR. BUTING: Let's turn to two pages further down, August 28th, analyst is K.W., right?
SHERRY CULHANE: Yes.
MR. BUTING: This is an example where a partial female profile was developed in a control and the analyst was completely unable to determine the origin of that profile, right?
SHERRY CULHANE: Correct.
MR. BUTING: It wasn't her -- I'm sorry, I'm assuming it's a her, looks like, do you know K.W.?
SHERRY CULHANE: Right.
MR. BUTING: Okay. It was not her DNA, right?
SHERRY CULHANE: Correct.
MR. BUTING: And it was not carryover, right?
SHERRY CULHANE: Correct.
MR. BUTING: It was determined as contamination that simply is unexplainable?
SHERRY CULHANE: That's correct.
MR. BUTING: The very one right before that, I believe it's Karen Daily; is that right? August 29th?
SHERRY CULHANE: Yes.
MR. BUTING: This one is actually a duplicate. If you look at the page, the first page of the running log.
SHERRY CULHANE: Okay.
MR. BUTING: I'm sorry, it's the second page of the running log that starts June 6th?
SHERRY CULHANE: Yes.
MR. BUTING: See, at the very bottom there, it says August 29th?
SHERRY CULHANE: Yes.
MR. BUTING: It says K.D.D., that's Karen Daily?
SHERRY CULHANE: Yes.
MR. BUTING: Another contamination in which she's finding alleles, some of which are similar to her and some of which are not?
SHERRY CULHANE: Correct.
MR. BUTING: A source that is completely unknown?
SHERRY CULHANE: That's correct.
MR. BUTING: And, finally, turn to March 16th of '06; do you see this page?
SHERRY CULHANE: Yes.
MR. BUTING: This is not you, right?
SHERRY CULHANE: Correct.
MR. BUTING: It's initialed M.R.S., it's a completely different case, right?
SHERRY CULHANE: Yes.
MR. BUTING: You weren't involved in the testing of that -- in that experiment at all?
SHERRY CULHANE: Not that I recall, no.
MR. BUTING: And yet this analyst found a partial profile in the control that was consistent with you?
SHERRY CULHANE: That's correct.
MR. BUTING: You ended up contaminating someone else's test?
SHERRY CULHANE: That's correct. My profile, partial profile, wasn't complete, so I'm assuming it was consistent with mine throughout.
MR. BUTING: All right. Now, your big profile, I'm sorry, protocol, that I think was entered even, as an exhibit, it recognizes that there may be some contamination in these tests, right?
SHERRY CULHANE: Yes.
MR. BUTING: And it says, it's got specific rules about what you can do, when you get a contamination?
SHERRY CULHANE: Yes.
MR. BUTING: And one of those rules in the protocol is, if you get a contaminated control, it forbids you from making a call to include somebody as the person in that DNA, right?
SHERRY CULHANE: Yes.
MR. BUTING: It tells you, that if you go through these tests and the manipulation control is contaminated, that you are to report it as inconclusive for matched purposes?
SHERRY CULHANE: Correct.
MR. BUTING: Now, here, you ran this test on the bullet and you got a result that shows the manipulation control was contaminated, right?
SHERRY CULHANE: Correct.
MR. BUTING: And according to protocol, you should have not said that that was Teresa Halbach's DNA on the bullet, your protocol told you that you were to report it as inconclusive; isn't that right?
SHERRY CULHANE: Yes.
MR. BUTING: But if that happens, usually what you do is you try and re-extract it and run it again?
SHERRY CULHANE: Yes.
MR. BUTING: But in this case, it was a one time deal, you put that bullet into a buffer and you took whatever sample there was and you ran it off?
SHERRY CULHANE: Yes.
MR. BUTING: So you could not redo the test?
SHERRY CULHANE: That's correct.
MR. BUTING: And if the test came back inconclusive, you would not be able to put Teresa Halbach in Mr. Avery's garage at any time, right, like Mr. Fassbender asked?
SHERRY CULHANE: There were reasons why --
MR. BUTING: I will get to that.
SHERRY CULHANE: There were reasons why this profile was reported on.
MR. BUTING: We'll talk about that. But my point is this, out of all these tests that you have done --
SHERRY CULHANE: Right.
MR. BUTING: -- not one single test put Teresa Halbach in Mr. Avery's garage?
SHERRY CULHANE: That's correct.
MR. BUTING: Except for this bullet.
SHERRY CULHANE: That's correct.
MR. BUTING: And this is the only one, right?
SHERRY CULHANE: Yes.
MR. BUTING: And you couldn't retest it, so you either had to call it inconclusive or else deviate from your protocol.
SHERRY CULHANE: That's correct.
MR. BUTING: Let's mark this exhibit.
(Exhibit No. 347 marked for identification.)
MR. BUTING: I now show you Exhibit 347, can you identify that?
SHERRY CULHANE: Yes.
MR. BUTING: And what is it?
SHERRY CULHANE: It's a copy of our deviation request form in our laboratory.
MR. BUTING: Okay. And this is a form that, if you want to deviate from your protocol in any way, you have to -- or any analyst has to fill out this form and it's to be reviewed by two people, right?
SHERRY CULHANE: It's to be reviewed by the Technical Unit Leader and approved by the supervisor.
MR. BUTING: Okay. And the Technical Unit person is who?
SHERRY CULHANE: Myself, in our lab, and Gretchen DeGroot in the Milwaukee lab.
MR. BUTING: Okay. So you had one person sign this, one person review this, and that is Gretchen DeGroot, right?
SHERRY CULHANE: That's correct.
MR. BUTING: You went all the way to the Milwaukee Lab to get approval to deviate from your protocol in order to make a call that says Teresa Halbach's DNA is on that bullet, right?
SHERRY CULHANE: No, sir. I discussed this with my supervisor in the laboratory. In fact, I discussed it with numerous analysts in the laboratory. And, yes, I did talk to Gretchen about it. Since this was a technical matter, and Gretchen and I are more in tune to the technical issues, she is the one I would have, as well as the peer reviewer who reviewed my case, that I would have talked to first, and I did talk to Marie, my supervisor.
MR. BUTING: You are familiar with the protocol?
SHERRY CULHANE: Yes, I am.
MR. BUTING: Record should reflect you are looking at Exhibit 310, right?
SHERRY CULHANE: Yes.
MR. BUTING: There you go. All right. In this section of your protocol, it says interpretation of STR results, right?
SHERRY CULHANE: Yes.
MR. BUTING: That's the heading and it talks about how it's a matter of professional judgment and expertise, right?
SHERRY CULHANE: Yes.
MR. BUTING: And it recognizes that maybe some situations may not fit a preset rule?
SHERRY CULHANE: Correct.
MR. BUTING: Gives some latitude for that, right?
SHERRY CULHANE: Right.
MR. BUTING: But it also says, any deviations must be documented in written form, prior to peer review; in those situations any deviations must be approved by the technical leader and the supervisor, right?
SHERRY CULHANE: Correct.
MR. BUTING: The exhibit in front of you, which is the unit deviation form, does not have any approval from the supervisor, does it?
SHERRY CULHANE: It has no signature, but I did discuss it with her and she did approve it.
MR. BUTING: But she didn't sign anything, is that what you are saying?
SHERRY CULHANE: Apparently it was an oversight.
MR. BUTING: Okay. All right. Thank you. Now, this kind of a deviation from protocol is a pretty unusual thing in your lab, right?
SHERRY CULHANE: Yes.
MR. BUTING: You don't do it very often?
SHERRY CULHANE: Right.
MR. BUTING: Twenty-three years you have been there, right?
SHERRY CULHANE: Yes.
MR. BUTING: This is the only time in your entire career you have ever filed a deviation of protocol so that you could make a call and include somebody, isn't it?
SHERRY CULHANE: Yes.
MR. BUTING: This case is the only time, right?
SHERRY CULHANE: Yes.
MR. BUTING: So, when Mr. Gahn asked you on direct whether -- when you did the exclusion of Mr. Avery in 2003, whether you followed the same steps there that you followed here, that's not entirely true, is it?
SHERRY CULHANE: I don't understand what you mean.
MR. BUTING: When you did the test that excluded Mr. Avery, proved he was wrongly convicted in 2003, you did not have to deviate from any protocol to make that call, did you?
SHERRY CULHANE: No, because our protocol doesn't require any deviation for an exclusion --
MR. BUTING: That's right.
SHERRY CULHANE: -- no matter what.
MR. BUTING: I'm sorry?
SHERRY CULHANE: No matter what.
MR. BUTING: Right. But there was no -- you didn't have to deviate anyway, you had no contamination in his test?
SHERRY CULHANE: Right. The protocols that I followed were all in the same -- I mean, they were all in place. That deviation was available if I had needed it. The request to make it was available.
MR. BUTING: But you didn't need to?
SHERRY CULHANE: No, I didn't.
MR. BUTING: But in this case you did?
SHERRY CULHANE: That's correct.
MR. BUTING: The one and only case in 23 years you did, right?
SHERRY CULHANE: This kind of deviation, first of all, in this context, we're talking about DNA evidence. And we haven't been doing DNA evidence for 23 years. So --
MR. BUTING: Well, you have been doing it since 1997?
SHERRY CULHANE: No. 19 -- Yeah, 1996, you are right.
MR. BUTING: Okay. Ten years, then, 50,000 -- 60,000 tests is what you have told Mr. Gahn, in your lab?
SHERRY CULHANE: Yes.
MR. BUTING: And whatever portion of that is yours, you have never filed a request to deviate from the protocol in order to make a call and say that's her DNA, until this case?
SHERRY CULHANE: That's correct, because we have never -- I have never had this situation before.
MR. BUTING: Turn to your reports, please. Do you have those in front of you?
SHERRY CULHANE: Yes.
MR. BUTING: I'm showing you Exhibit 314. Let's talk about it in terms of exhibit numbers, okay. Is that your report that's dated May 8, 2006?
SHERRY CULHANE: Yes, it is.
MR. BUTING: And that is the report that says -- gives a result of this test of the bullet?
SHERRY CULHANE: Correct.
MR. BUTING: Correct?
SHERRY CULHANE: Yes.
MR. BUTING: Now, these reports are very important, right?
SHERRY CULHANE: Yes.
MR. BUTING: These are your final reports?
SHERRY CULHANE: Yes.
MR. BUTING: For that test? They are signed by yourself?
SHERRY CULHANE: Correct.
MR. BUTING: And by Marie Beth Varriale?
SHERRY CULHANE: Correct.
MR. BUTING: Who's the supervisor of the lab, your unit?
SHERRY CULHANE: Yes.
MR. BUTING: And she's signing it as the designee for the Attorney General of the State of Wisconsin, correct?
SHERRY CULHANE: Yes.
MR. BUTING: That's how important these reports are. They are from the Attorney General.
SHERRY CULHANE: That's correct.
MR. BUTING: And you know how these reports are used, correct?
SHERRY CULHANE: Yes.
MR. BUTING: Courts rely on them?
SHERRY CULHANE: Yes.
MR. BUTING: Juries rely on them?
SHERRY CULHANE: Yes.
MR. BUTING: Prosecutors and police rely on them?
SHERRY CULHANE: Yes.
MR. BUTING: Defense attorneys rely on them?
SHERRY CULHANE: That's correct.
MR. BUTING: Now, on Page 2 of your report -- I'm sorry, it's page 4, you have a sentence in there, at the end of the first paragraph, that says -- Actually, the first paragraph says the profile is developed from the bullet fragment --
(Court reporter asked the attorney to repeat.)
MR. BUTING: I'm sorry.
MR. BUTING: The profiles developed from the bullet fragment, Item FL, in the interior driver's door handle, Item IG, are consistent with the profile developed from the Pap smear, Item EF, reportedly collected from Teresa Halbach. And then it refers to a prior report.
And then the last sentence, the manipulation control extracted with the bullet fragment, Item FL, contains DNA that is consistent with this analyst?
SHERRY CULHANE: Correct.
MR. BUTING: All right. At no time, in this report, do you ever disclose, that in order to make that finding, you had to deviate from a protocol, did you?
MR. BUTING: Anyone reading this report would never know that, in order for you to make that call and say that that's Teresa Halbach's DNA, you had to do something you have never done in your career as a Crime Lab analyst, right?
SHERRY CULHANE: Without discovery, no.
MR. BUTING: So, if a defense attorney, or Court, didn't dig through all of those mass of papers that you have there and find this unit one page report, no one would ever know that, in order for you to make that call in this case, you had to do something you have never done before?
SHERRY CULHANE: The deviation that I requested was appropriate for this situation. And the results that I reported were correct. And that's why the deviation was requested. All my data supported the deviation, it was okayed --
MR. BUTING: But --
SHERRY CULHANE: -- and it was reported.
MR. BUTING: -- ma'am, you did not disclose, in that report, that official report, that Courts, and juries, and judges, and lawyers, and everybody else relies on, you did not disclose that in order to make that call you had to do something so rare you have never done it before, did you?
SHERRY CULHANE: No, I did not.
MR. BUTING: And you didn't put that in there because if you did, you wouldn't be able to satisfy Mr. Fassbender's request that you put Teresa Halbach in Steven Avery's garage, right?
SHERRY CULHANE: That's not correct.
MR. BUTING: Let's close with this. Other than that bullet, all your other tests, none of them put Teresa Halbach, ever, in his garage, or his house, or any of his vehicles, right?
SHERRY CULHANE: Correct.
MR. BUTING: Thank you.
THE COURT: We're going to take a 10 minute break at this time. And then we'll resume.
(Jury not present.)
THE COURT: You may be seated. All right. Counsel, I will see you in 10 minutes.
MR. BUTING: Ten, you said?
THE COURT: Yes, I'm giving the court reporter a break. We'll take another one before the afternoon is over.
(Recess taken.)
THE COURT: Mr. Gahn, do you have any questions on redirect?
THE COURT: You may begin.
REDIRECT EXAMINATION BY ATTORNEY GAHN:
MR. GAHN: Ms Culhane, will you explain to the jurors exactly what it is that goes into a report, a final report that you file in a case?
SHERRY CULHANE: The content of the report is usually everything that we examined, of all the items submitted, exactly what we examined; a description of the technology that we're using; the types -- sometimes, not always -- the actual types go into the report; and then our results, with reference to our profiles we developed, whether they are inconsistent or consistent; and a final conclusion.
MR. GAHN: You indicated in your report when you read about the bullet, Item FL, that Teresa Halbach's profile was contained on that bullet, correct?
SHERRY CULHANE: That's correct.
MR. GAHN: And you also indicated in your report that your profile was contained in the control; is that correct?
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
MR. GAHN: And anyone reading your report would have seen that your profile was in the control, correct?
SHERRY CULHANE: Yes.
MR. BUTING: Objection, speculation.
THE COURT: Sustained.
MR. GAHN: (By Attorney Gahn)~ But further information about your profile in the control was contained in all of your notes?
SHERRY CULHANE: That's correct.
SHERRY CULHANE: Yes.
MR. GAHN: Similarly, with the contamination log that Mr. Buting showed you, you turned your contamination log over to the defense, correct?
SHERRY CULHANE: Correct.
SHERRY CULHANE: Several different purposes, actually. We use it to troubleshoot, to find out if we're having a systemic problem in the lab, to make sure that our reagents are clean, to make sure that we haven't inadvertently contaminated our reagents or something and that way we would be introducing DNA into our samples. That's one function.
The other function is to troubleshoot each situation as it happens. If you further look at that contamination log, I would guess 99 percent of the instances that we had were resolved, either by reworking the case, or by the fact that the evidence was actually an elimination or it excluded someone. So it, basically, provides us with the information to, if we have those instances, to troubleshoot and try and find out what happened in that particular case.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
SHERRY CULHANE: May of 2006.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Not to my knowledge.
SHERRY CULHANE: Because it happens. Any type of lab work where you have human beings doing the work, the possibility for these types of contamination are going to happen. It's unavoidable.
The techniques that we're working with are extremely sensitive. And, actually, that's why they are so useful. They are very sensitive because they do pick up on small amounts of DNA.
But taking that into account, you also have to realize that contamination is going to happen. And it's interpreted and dealt with on a case by case basis.
MR. GAHN: Does the scientific community recognize that contamination is a possibility or a risk in the DNA PCR testing process?
SHERRY CULHANE: Yes.
MR. GAHN: And have studies been conducted about the contamination risks using this type of methodology?
SHERRY CULHANE: Yes.
MR. GAHN: Is it well documented that there are risks of contamination with this type of technology?
SHERRY CULHANE: Yes.
MR. GAHN: Do the manufacturers of the kits and the equipment that you have in your laboratory recognize contamination?
SHERRY CULHANE: Yes, they do.
SHERRY CULHANE: I assume so, I'm not 100 percent familiar with that.
MR. BUTING: Objection, I move to strike the answer.
THE COURT: Court will order the answer stricken.
MR. GAHN: (By Attorney Gahn)~ And, again, would you explain to the jurors why this testing methodology is so sensitive and the ability to -- the ability it has to pick up trace amounts of DNA?
SHERRY CULHANE: The PCR reaction that we use to copy all of these genetic markers that I'm talking about works on very small pieces of DNA. So, if you have DNA that has been compromised by environmental factors such as heat, UV light; if you have substrates like soil, or wood, or things like that that may compromise the sample; PCR is very good for that. Because even though the DNA is chewed up a little bit, there's still usually enough there to amplify or make a whole lot of copies. So this amplification process gives us a lot of material, after it's completed, to work with.
Because of that fact, it also amplifies very, very small amounts of DNA, so, such as in this case, my DNA -- my DNA being introduced into the negative control, even though it was a very, very small amount, the technique was sensitive enough to pick that up.
MR. GAHN: Would you explain to the jurors the exact set up of your evidence and your control during an extraction?
SHERRY CULHANE: I have a test tube rack in front of me. And say, for instance, I'm doing three evidence samples, so I'm going to have three separate tubes labeled with the number and the item designation for each item of evidence. And then I'm going to have a fourth tube that's referred to as the manipulation control.
As I sample each one of my samples, depending on whether it's a cutting or what the evidence is, if it's a cutting, I will cut a portion of the swab or material off, put it into the tube and close the cap; clean my scissors and forceps off; go to the next item, put it in the tube, close the cap. I do that for all the evidence items.
And, then, the control, I actually just add to the liquid the buffers that cause the reaction to happen. And that all takes place on my bench top, in a test tube rack; I have a piece of white paper down on my desk.
MR. GAHN: Now, while you were performing this extraction what else were you doing? Were you training anyone?
SHERRY CULHANE: Concerning the bullet, right?
SHERRY CULHANE: Concerning the bullet, this was a little bit unusual, because there was nothing to cut. And there was nothing -- I didn't feel like, by swabbing it, that I would get enough DNA off of the item, so I actually put the entire bullet into the tube, with my reagents, and washed all the DNA off that was on that tube.
Because this was a little unusual, most of our samples are swabbings or cuttings, I had two of our newer analysts sit next to my workbench and watch me. And as I was doing it, I was explaining what I was doing and why I was doing it. And I felt like I was far enough away from my workbench so that my talking wouldn't interfere; but, obviously, that was incorrect.
MR. GAHN: If when -- If your DNA profile had been on the bullet, would that have changed anything?
SHERRY CULHANE: Yes.
SHERRY CULHANE: If my DNA had been on the evidence sample, I would have reported that as a mixture of DNA from myself and Teresa Halbach and I would have done a statistical analysis referred to as a likelihood ratio. That type of contamination is different than what actually happened.
MR. GAHN: If your -- If the control in this case had contained a DNA profile that was unrecognizable to you, would that have changed anything?
SHERRY CULHANE: Yes.
SHERRY CULHANE: I would not have requested a deviation because it would not have been appropriate; it would have been inconclusive, just like our protocol calls for.
SHERRY CULHANE: First of all, there were a couple of reasons, my DNA was in the control, not the evidence sample. And because I was the analyst using it -- processing it, I knew what the source of the DNA was. And I felt this was probative evidence, and I felt it was appropriate simply -- primarily because it was my own DNA and it was in the evidence sample.
Had it been any other profile, had it been mixed with the sample, again, I would have reported it, but I would have reported it as a mixture, and all the information would have been in my report just like it was in this report.
All the information was there, but I felt it was appropriate because I could not go back and re-extract. I was stuck with what I had; I couldn't redo anything to remedy the situation. And I felt it was probative evidence, so I reported it.
MR. GAHN: Did the presence of your DNA profile in the control, in any way, cause the presence of Teresa Halbach's DNA profile on the bullet?
SHERRY CULHANE: It was a single source of DNA, meaning from one person, and it was consistent with Teresa Halbach.
SHERRY CULHANE: Correct.
MR. GAHN: I believe you testified on direct examination that since January 1st of 2001, the Crime Lab has analyzed -- was it over 50,000 samples?
SHERRY CULHANE: Correct.
MR. GAHN: And did you also testify that you have logged, since that time, 89 instances of contamination?
SHERRY CULHANE: That's correct.
SHERRY CULHANE: Yes.
SHERRY CULHANE: I was examining pubic hairs that were originally submitted back in '85. In 1985 we did a microscopic comparison of hairs. That was state-of-the-art, that's what every crime lab did.
At the time, I made no statement about the pubic hair combings because, microscopically, I could not tell the difference between the victim and the suspect's pubic hairs. So if I couldn't tell the difference I certainly couldn't tell if any of these pubic hairs were foreign, so that was inconclusive.
When I was asked by Project Innocence to go back and look at these hairs, they were all mounted on microscope slides that I had originally mounted them on in 1985. I removed the cover slip; I took the hairs off; I washed the hairs; and I attempted to extract DNA from them.
You probably remember me telling you that the type of DNA testing that we're doing is only appropriate if you have nucleated cells. So the hair shaft, we couldn't get DNA from, it had to be the root of the hair, if there was some skin attached to it.
And in this case I extracted 11 hairs, two of them did have cellular material; one was consistent with a woman and one was consistent with a male.
SHERRY CULHANE: Yes.
MR. GAHN: Tell the jurors about the potential for getting a DNA profile from the root of a single hair?
SHERRY CULHANE: Traditionally --
MR. BUTING: Objection, this is irrelevant, I think.
THE COURT: Well, there were some questions on cross about it, I will allow her to explain what she did.
SHERRY CULHANE: In most cases, again, unless there is cellular material attached to the root of the hair, we don't have a lot of success with nuclear hair -- I mean nuclear DNA off of -- which is the type of DNA we're doing, off of hair, in general. To get DNA off of a hair that old, that was mounted on a microscope slide, was pretty unusual.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
MR. GAHN: Mr. Buting stated that the profile you developed from that one single hair was responsible to free Mr. Avery; is that correct?
SHERRY CULHANE: Yes.
MR. GAHN: And you ran that profile through the data bank and it hit on an individual by the name of Gregory Allen; is that correct?
SHERRY CULHANE: Yes.
MR. GAHN: Ms Culhane, if by chance your DNA profile had been in the control of that case, would you have not reported Gregory Allen as the person with the profile on the hair?
SHERRY CULHANE: No, I would have requested a deviation from our protocol because --
MR. BUTING: Objection, speculation here.
THE COURT: No, I think there actually were some questions about this on cross, so I'm going to allow it.
SHERRY CULHANE: I would have requested a deviation in that particular case too because I couldn't go back and redo that hair. I had one shot, and if I got contamination, and it would have been my DNA in the manipulation control, I would have requested a deviation.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
MR. GAHN: Just like when you analyzed the one hair in 2003, that resulted in Steven Avery's freedom?
MR. BUTING: Objection, no comparison.
THE COURT: It's been asked and answered. Sustained.
MR. GAHN: (By Attorney Gahn)~ Now, Ms Culhane, Mr. Buting handed you, before, Exhibit 344, and I will have it brought up to you in just a moment. But this was an exhibit that listed the buccal swab of Steven Avery being returned to the Manitowoc County Sheriff's Department; is that correct?
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes, this is a copy of our receipt.
SHERRY CULHANE: A buccal swab.
SHERRY CULHANE: Yes.
SHERRY CULHANE: Yes.
MR. GAHN: And what happens when you are finished with a case, explain to the jurors how it's packaged up and how it is sent back to the submitting agency?
SHERRY CULHANE: When I finish with a case, it's put pack in the original container and it's sealed with evidence tape, or whatever tape we have in the laboratory, usually evidence tape. And our initial -- my initials are across the seal.
MR. GAHN: And if that envelope that you returned the buccal swabs in was still in that condition today, would you be able to recognize it?
SHERRY CULHANE: I believe so.
(Exhibit No. 348, marked for identification.)
SHERRY CULHANE: If my initials are on there, I will recognize them.
MR. BUTING: Can I see it, please?
MARK WIEGERT: 348.
MR. GAHN: (By Attorney Gahn)~ Detective Wiegert is going to hand you what has been marked as Exhibit 348 and ask if that has any markings on the outside of the envelope that you recognize?
SHERRY CULHANE: Yes, it does.
SHERRY CULHANE: This is the evidence tape we use in the laboratory. Those are my initials. And this is also the label for our case number.
THE COURT: Mr. Buting, I'm going to have to ask you if you agree, since I really can't see very well.
MR. BUTING: Point to it.
THE COURT: It is a blue label. Looks like a blue label.
MR. BUTING: Sure.
THE COURT: All right. The record will so reflect.
SHERRY CULHANE: And my initials are also across that label.
MR. BUTING: Objection, hold on, I don't want --
THE COURT: I'm going to sustain the objection. The defense may have the right to ask questions on recross that might pertain to the current state of the envelope. I will let you address opening it after recross is finished. Fair enough?
MR. BUTING: Sure.
THE COURT: Okay.
MR. GAHN: (By Attorney Gahn)~ Does the case number on that exhibit correspond to the case number on the -- on Exhibit, is it 344, the transmittal evidence form?
SHERRY CULHANE: Yes, it does.